<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Immunology1664-3224Frontiers Media S.A. pmcid: 7198842 doi: 10.3389/fimmu.2020.00695 : Immunology: Review" exact="Disease" post="Resolution in Chikungunya—What Decides the Outcome? SrivastavaPriyanshu†KumarAnkit†HasanAbdulMehtaDivyaKumarRameshSharmaChetanSunilSujatha*[], Vector-Borne Diseases"/>
 <result pre="Review Disease Resolution in Chikungunya—What Decides the Outcome? SrivastavaPriyanshu†KumarAnkit†HasanAbdulMehtaDivyaKumarRameshSharmaChetanSunilSujatha*[], Vector-Borne" exact="Diseases" post="Group, International Centre for Genetic Engineering and Biotechnology (ICGEB)New"/>
 <result pre="France *Correspondence: Sujatha Sunil sujatha@icgeb.res.in This article was submitted to" exact="Viral" post="Immunology, a section of the journal Frontiers in Immunology"/>
 <result pre="permitted which does not comply with these terms. Abstract Chikungunya" exact="disease" post="(CHIKD) is a viral infection caused by an alphavirus,"/>
 <result pre="comply with these terms. Abstract Chikungunya disease (CHIKD) is a" exact="viral infection" post="caused by an alphavirus, chikungunya virus (CHIKV), and triggers"/>
 <result pre="with these terms. Abstract Chikungunya disease (CHIKD) is a viral" exact="infection" post="caused by an alphavirus, chikungunya virus (CHIKV), and triggers"/>
 <result pre="disease (CHIKD) is a viral infection caused by an alphavirus," exact="chikungunya" post="virus (CHIKV), and triggers large outbreaks leading to epidemics."/>
 <result pre="health concern owing to high morbidity in affected individuals. The" exact="complete" post="spectrum of this disease can be divided into four"/>
 <result pre="high morbidity in affected individuals. The complete spectrum of this" exact="disease" post="can be divided into four phases based on its"/>
 <result pre="the innate immune system to enter into circulation and reach" exact="primary" post="sites of infection such as the lymph nodes, spleen,"/>
 <result pre="system to enter into circulation and reach primary sites of" exact="infection" post="such as the lymph nodes, spleen, and liver. Also,"/>
 <result pre="liver. Also, at this point, antigen-presenting cells (APCs) present the" exact="viral" post="antigens to the T cells thereby activating and initiating"/>
 <result pre="as fever, rashes, arthralgia, and myalgia and is termed the" exact="acute" post="phase of the disease. Viremia reaches its peak during"/>
 <result pre="post-acute phase. Immune responses mounted during this phase of the" exact="infection" post="determine the degree of disease progression or its resolution."/>
 <result pre="during this phase of the infection determine the degree of" exact="disease" post="progression or its resolution. Some patients may progress to"/>
 <result pre="progression or its resolution. Some patients may progress to a" exact="chronic" post="arthritic phase of the disease that may last from"/>
 <result pre="or its resolution. Some patients may progress to a chronic" exact="arthritic" post="phase of the disease that may last from a"/>
 <result pre="patients may progress to a chronic arthritic phase of the" exact="disease" post="that may last from a few months to several"/>
 <result pre="a few months to several years, owing to a compromised" exact="disease" post="resolution. The present review discusses the immunopathology of CHIKD"/>
 <result pre="discusses the immunopathology of CHIKD and the factors that dictate" exact="disease" post="progression and its resolution. chikungunya virus incubation phase acute"/>
 <result pre="and the factors that dictate disease progression and its resolution." exact="chikungunya" post="virus incubation phase acute phase immunopathology disease resolution chronic"/>
 <result pre="dictate disease progression and its resolution. chikungunya virus incubation phase" exact="acute" post="phase immunopathology disease resolution chronic phase chikungunya induced arthritis"/>
 <result pre="and its resolution. chikungunya virus incubation phase acute phase immunopathology" exact="disease" post="resolution chronic phase chikungunya induced arthritis viral clearance Funding"/>
 <result pre="resolution. chikungunya virus incubation phase acute phase immunopathology disease resolution" exact="chronic" post="phase chikungunya induced arthritis viral clearance Funding International Center"/>
 <result pre="virus incubation phase acute phase immunopathology disease resolution chronic phase" exact="chikungunya" post="induced arthritis viral clearance Funding International Center for Genetic"/>
 <result pre="phase acute phase immunopathology disease resolution chronic phase chikungunya induced" exact="arthritis" post="viral clearance Funding International Center for Genetic Engineering and"/>
 <result pre="acute phase immunopathology disease resolution chronic phase chikungunya induced arthritis" exact="viral" post="clearance Funding International Center for Genetic Engineering and Biotechnology10.13039/100007675Core"/>
 <result pre="Biotechnology10.13039/100007675Core Fund fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction Chikungunya" exact="disease" post="(CHIKD), caused by an arthritogenic alphavirus, chikungunya virus (CHIKV),"/>
 <result pre="word-count: Introduction Chikungunya disease (CHIKD), caused by an arthritogenic alphavirus," exact="chikungunya" post="virus (CHIKV), is becoming a major public health hazard"/>
 <result pre="The past few decades have seen the re-emergence of this" exact="viral infection" post="as evidenced by epidemics in Africa, Asia, Europe and,"/>
 <result pre="past few decades have seen the re-emergence of this viral" exact="infection" post="as evidenced by epidemics in Africa, Asia, Europe and,"/>
 <result pre="years, the Americas (3, 4). The first report of this" exact="infection" post="dates back to the 1900s; it was then confused"/>
 <result pre="in the La Reunion islands where Aedes albopictus was the" exact="primary" post="vector (6–8). It was identified that specific mutations in"/>
 <result pre="vector (6–8). It was identified that specific mutations in the" exact="viral" post="E1 glycoprotein provided fitness to the virus by reducing"/>
 <result pre="involving both mosquito species (9, 11). CHIKD is primarily a" exact="viral infection" post="manifested as a fever with severe arthritic joint involvement."/>
 <result pre="both mosquito species (9, 11). CHIKD is primarily a viral" exact="infection" post="manifested as a fever with severe arthritic joint involvement."/>
 <result pre="primarily a viral infection manifested as a fever with severe" exact="arthritic" post="joint involvement. Rightly so, the disease was named &quot;Chikungunya,�?"/>
 <result pre="a fever with severe arthritic joint involvement. Rightly so, the" exact="disease" post="was named &quot;Chikungunya,�? which in Makonde means &quot;that which"/>
 <result pre="the affected individuals which disables movement (12). Even though the" exact="infection" post="is classically characterized by fever and joint pains that"/>
 <result pre="sequelae involving joint pains for a few weeks (13), the" exact="disease" post="can last up to 2–3 years in a small"/>
 <result pre="neurological complications in patients stemming from the involvement of the" exact="central nervous system" post="(16, 17) as well as an impaired immune system"/>
 <result pre="mother and unborn child and results in complications such as" exact="encephalopathy" post="(22, 23). CHIKD establishes itself and progresses to a"/>
 <result pre="of intrinsic incubation before the clinical symptoms appear and the" exact="disease" post="progresses. The disease can then be clinically categorized into"/>
 <result pre="before the clinical symptoms appear and the disease progresses. The" exact="disease" post="can then be clinically categorized into acute, post-acute, and"/>
 <result pre="disease can then be clinically categorized into acute, post-acute, and" exact="chronic" post="phases that can last for a few days up"/>
 <result pre="established that host immunity can play an important role in" exact="disease" post="progression and its resolution after an acute phase of"/>
 <result pre="important role in disease progression and its resolution after an" exact="acute" post="phase of the disease (26–28). The innate immune system"/>
 <result pre="progression and its resolution after an acute phase of the" exact="disease" post="(26–28). The innate immune system has shown to be"/>
 <result pre="be protective, which may result in early resolution of the" exact="disease" post="as evaluated in some reports (29, 30). At the"/>
 <result pre="reported to be instrumental in mounting the severity of the" exact="disease" post="and resulting in the chronic arthritic condition that could"/>
 <result pre="mounting the severity of the disease and resulting in the" exact="chronic" post="arthritic condition that could last for years (26, 31,"/>
 <result pre="the severity of the disease and resulting in the chronic" exact="arthritic" post="condition that could last for years (26, 31, 32)."/>
 <result pre="for years (26, 31, 32). Recent research has attributed several" exact="viral" post="factors that could also contribute to alleviated chronic conditions,"/>
 <result pre="attributed several viral factors that could also contribute to alleviated" exact="chronic" post="conditions, such as persistence of defective viral particles in"/>
 <result pre="contribute to alleviated chronic conditions, such as persistence of defective" exact="viral" post="particles in the host (33) and prolonged infection of"/>
 <result pre="of defective viral particles in the host (33) and prolonged" exact="infection" post="of synovial macrophages (24). The current review is a"/>
 <result pre="compilation of the immunopathological events that take place during the" exact="acute" post="and post-acute phases of CHIKD that may either lead"/>
 <result pre="of CHIKD that may either lead to resolution of the" exact="disease" post="or contribute to an exaggerated immune response, resulting in"/>
 <result pre="contribute to an exaggerated immune response, resulting in a full-blown" exact="arthritic" post="chronic phase lasting up-to several years (Figure 1). Figure"/>
 <result pre="to an exaggerated immune response, resulting in a full-blown arthritic" exact="chronic" post="phase lasting up-to several years (Figure 1). Figure 1"/>
 <result pre="virus into the dermis and epidermis of the skin. The" exact="viral infection" post="is characterized by an incubation period of which is"/>
 <result pre="into the dermis and epidermis of the skin. The viral" exact="infection" post="is characterized by an incubation period of which is"/>
 <result pre="by an incubation period of which is followed by the" exact="acute" post="phase during which a rapid rise in viremia occurs"/>
 <result pre="and clinical symptoms such as joint pain, fever, maculopapular and" exact="petechial rash" post="appear. As the viral load increases the host innate"/>
 <result pre="joint pain, fever, maculopapular and petechial rash appear. As the" exact="viral" post="load increases the host innate and adaptive immune responses"/>
 <result pre="resolved from the host. Despite the robust host immune response," exact="viral" post="particles persist in the synovial fluid of joints and"/>
 <result pre="fluid of joints and alter joint pathology resulting in a" exact="chronic" post="phase that lasts for months/years. Acute Phase Early Events"/>
 <result pre="pathology resulting in a chronic phase that lasts for months/years." exact="Acute" post="Phase Early Events Leading to the Establishment of CHIKV"/>
 <result pre="Acute Phase Early Events Leading to the Establishment of CHIKV" exact="Infection" post="The pre-acute phase or the incubation period of CHIKD"/>
 <result pre="(39). At the same time, the mosquito also punctures nearby" exact="blood vessels," post="allowing the virus to enter the bloodstream as evidenced"/>
 <result pre="site of a mosquito bite, the resident cells of the" exact="cutaneous" post="immune system defend the host from the pathogen. The"/>
 <result pre="cutaneous immune system defend the host from the pathogen. The" exact="cutaneous" post="immune system acts as the first line of defense"/>
 <result pre="such as the lymphocytes, dendritic cells (DCs), and monocytes (39)." exact="Gamma" post="delta T lymphocytes (γδ T cells) constitute the most"/>
 <result pre="cells are present in the skin, the local site of" exact="infection" post="for CHIKV, and lack the major histocompatibility complex (MHC)"/>
 <result pre="processing and thus can react to the unprocessed antigens (43)." exact="Infection" post="of CHIKV in mice (footpad) led to a significant"/>
 <result pre="Further, mice deficient in γδ T cells had an increased" exact="disease" post="severity accompanied by histopathologic changes (45, 46). Skin resident"/>
 <result pre="such as langerhans cells encounter antigens at the site of" exact="infection" post="and may disseminate the virus to draining lymph nodes"/>
 <result pre="mechanism) have documented the role of bite-induced enhancement of arboviral" exact="infection" post="(47–50). Studies have indicated that mosquito saliva has immune-modulatory"/>
 <result pre="immune response (39, 47, 51, 52). One such study of" exact="CHIKV infection" post="in mice models observed changes in cutaneous cytokine profiles"/>
 <result pre="response (39, 47, 51, 52). One such study of CHIKV" exact="infection" post="in mice models observed changes in cutaneous cytokine profiles"/>
 <result pre="study of CHIKV infection in mice models observed changes in" exact="cutaneous" post="cytokine profiles when inoculating the virus with a needle"/>
 <result pre="when inoculating the virus with a needle or mimicking natural" exact="infection" post="using mosquitoes. Needle inoculation of the virus into mice"/>
 <result pre="expression of TLR3 and Th1 cytokines (IFN-γ and IL2) whereas" exact="infection" post="by mosquito bite elicited a Th2 cytokine response with"/>
 <result pre="of mosquito saliva showed that mice previously sensitized with a" exact="salivary gland" post="extract of mosquitoes have more robust cellular infiltration than"/>
 <result pre="recent study correlated the initial events of mosquito bite and" exact="viral" post="inoculation with subsequent development of systemic disease, highlighting an"/>
 <result pre="of mosquito bite and viral inoculation with subsequent development of" exact="systemic" post="disease, highlighting an important role for cutaneous innate immune"/>
 <result pre="subsequent development of systemic disease, highlighting an important role for" exact="cutaneous" post="innate immune response. The study observed that stromal cells"/>
 <result pre="are less abundant in the dermis, were major activators of" exact="type I" post="IFN response at the initial inoculation site and therefore"/>
 <result pre="initial inoculation site and therefore were major players in limiting" exact="viral" post="replication and clinical progression (56). However, other studies have"/>
 <result pre="and engage cells of the adaptive immune response (47, 51)." exact="Infections" post="with Semliki forest virus aided or unaided by mosquito"/>
 <result pre="showed no reduction in IFN-γ levels, suggesting no perturbations of" exact="cutaneous" post="antiviral immunity (47). The authors showed that in the"/>
 <result pre="nodes, slowing the initial innate immune response activation and enhancing" exact="cutaneous" post="cell replication. Second, an influx of neutrophils attracted by"/>
 <result pre="cutaneous cell replication. Second, an influx of neutrophils attracted by" exact="cutaneous" post="cells was observed beginning from 90 min of infection"/>
 <result pre="by cutaneous cells was observed beginning from 90 min of" exact="infection" post="in the presence of mosquito saliva (47). Although neutrophils"/>
 <result pre="attracted cells of the myeloid lineage as new targets for" exact="viral" post="replication. Myeloid cells are also responsible for spreading the"/>
 <result pre="of infection, and neutrophil depletion at the bite site reduced" exact="viral" post="dissemination (47). The importance of type I IFNs during"/>
 <result pre="the bite site reduced viral dissemination (47). The importance of" exact="type I" post="IFNs during early infection is evidenced by IFNAR-deficient mice"/>
 <result pre="dissemination (47). The importance of type I IFNs during early" exact="infection" post="is evidenced by IFNAR-deficient mice models of CHIKV infection"/>
 <result pre="during early infection is evidenced by IFNAR-deficient mice models of" exact="CHIKV infection" post="in which mice died within 3 days post CHIKV"/>
 <result pre="early infection is evidenced by IFNAR-deficient mice models of CHIKV" exact="infection" post="in which mice died within 3 days post CHIKV"/>
 <result pre="CHIKV infection in which mice died within 3 days post" exact="CHIKV infection." post="Skin fibroblast cells upon infection by CHIKV virus were"/>
 <result pre="within 3 days post CHIKV infection. Skin fibroblast cells upon" exact="infection" post="by CHIKV virus were found to be major producers"/>
 <result pre="by CHIKV virus were found to be major producers of" exact="type I" post="IFNs (Specifically IFN-β). IFN production in these cells was"/>
 <result pre="infection, thus leading to a strong anti-viral defense early during" exact="CHIKV infection" post="(57). Establishment of the Acute Phase of Infection The"/>
 <result pre="thus leading to a strong anti-viral defense early during CHIKV" exact="infection" post="(57). Establishment of the Acute Phase of Infection The"/>
 <result pre="anti-viral defense early during CHIKV infection (57). Establishment of the" exact="Acute" post="Phase of Infection The beginning of the acute phase"/>
 <result pre="during CHIKV infection (57). Establishment of the Acute Phase of" exact="Infection" post="The beginning of the acute phase is marked by"/>
 <result pre="of the Acute Phase of Infection The beginning of the" exact="acute" post="phase is marked by viral dissemination from the local"/>
 <result pre="Infection The beginning of the acute phase is marked by" exact="viral" post="dissemination from the local site of replication to the"/>
 <result pre="viral dissemination from the local site of replication to the" exact="primary" post="sites of CHIKV infection in the host body (24)."/>
 <result pre="the local site of replication to the primary sites of" exact="CHIKV infection" post="in the host body (24). Hallmarks of the acute"/>
 <result pre="local site of replication to the primary sites of CHIKV" exact="infection" post="in the host body (24). Hallmarks of the acute"/>
 <result pre="CHIKV infection in the host body (24). Hallmarks of the" exact="acute" post="phase are peak viremia, manifestation of clinical symptoms, and"/>
 <result pre="of clinical symptoms, and production of neutralizing antibodies (58–60). The" exact="acute" post="phase of CHIKD typically lasts for 7–14 days (37,"/>
 <result pre="the general observation is that CHIKV-induced immunopathology is considered the" exact="primary" post="mediator of damage and persistent pain. Viral replication in"/>
 <result pre="is considered the primary mediator of damage and persistent pain." exact="Viral" post="replication in fibroblast cells (primary site of infection) is"/>
 <result pre="replication in fibroblast cells (primary site of infection) is initially" exact="limited" post="by a rapid and robust induction of interferons (IFN-β)"/>
 <result pre="cells. This sensing may involve the specific pathogen-associated motifs like" exact="viral" post="nucleic acids, that are recognized by pattern recognition molecules/receptors"/>
 <result pre="Class I—NOD-like Receptors (NLRs), retinoic inducible gene-I like receptors (RLRs)," exact="melanoma" post="differentiation factor (MDA)-5, laboratory of genetics and physiology (LGP)-2,"/>
 <result pre="the NLR family were associated with peak inflammatory symptoms during" exact="CHIKV infection" post="and these effects could be reversed upon the usage"/>
 <result pre="NLR family were associated with peak inflammatory symptoms during CHIKV" exact="infection" post="and these effects could be reversed upon the usage"/>
 <result pre="or NLRP3 inhibitors (65). Previously, the role of inflammasomes in" exact="CHIKV infection" post="was explored through in-vitro studies using siRNA targeting caspase-1"/>
 <result pre="NLRP3 inhibitors (65). Previously, the role of inflammasomes in CHIKV" exact="infection" post="was explored through in-vitro studies using siRNA targeting caspase-1"/>
 <result pre="of interferon induction (69) and TRIF knockout mice showed high" exact="viral" post="titer with increased foot swelling in comparison to WT"/>
 <result pre="showed high viremia but no difference in the severity of" exact="disease" post="in comparison to WT infected mice (70), implying that"/>
 <result pre="implying that MyD88 dependent pathway may not be involved in" exact="disease" post="progression. However, another study showed a significant role of"/>
 <result pre="study showed a significant role of MyD88 signaling in controlling" exact="viral" post="dissemination (57). Transcriptional analyses of peripheral blood from CHIKV"/>
 <result pre="MyD88 signaling in controlling viral dissemination (57). Transcriptional analyses of" exact="peripheral" post="blood from CHIKV infected patients showed a high expression"/>
 <result pre="CHIKV infected patients showed a high expression of viperin in" exact="monocyte" post="(71). The role of viperin was further evaluated using"/>
 <result pre="virus utilizes this cellular response to increase its rate of" exact="infection" post="and since the viral particles are sequestered within the"/>
 <result pre="response to increase its rate of infection and since the" exact="viral" post="particles are sequestered within the apoptotic blebs, it escapes"/>
 <result pre="apoptotic blebs by neighboring phagocytic cells such as macrophages promotes" exact="infection" post="in a non-inflammatory or dormant manner (74). As the"/>
 <result pre="manner (74). As the virus replicates, it simultaneously invades nearby" exact="blood vessels." post="Evidence has demonstrated the infection of blood monocytes by"/>
 <result pre="it simultaneously invades nearby blood vessels. Evidence has demonstrated the" exact="infection" post="of blood monocytes by CHIKV virus (75). The virus"/>
 <result pre="virus continues replication, achieving a peak in viremia during the" exact="acute" post="phase. Immunopathology of Acute Phase As CHIKV infection spreads,"/>
 <result pre="a peak in viremia during the acute phase. Immunopathology of" exact="Acute" post="Phase As CHIKV infection spreads, host immune responses are"/>
 <result pre="viremia during the acute phase. Immunopathology of Acute Phase As" exact="CHIKV infection" post="spreads, host immune responses are activated by engaging various"/>
 <result pre="during the acute phase. Immunopathology of Acute Phase As CHIKV" exact="infection" post="spreads, host immune responses are activated by engaging various"/>
 <result pre="lymphocytes to control this spread. A major event in the" exact="acute" post="phase is infiltration of macrophages, neutrophils, natural killer (NK)"/>
 <result pre="neutrophils, natural killer (NK) cells, and other lymphocytes to the" exact="primary" post="sites of infection, mainly joints and muscles, leading to"/>
 <result pre="primary sites of infection, mainly joints and muscles, leading to" exact="hypertrophy" post="in the cells of synovial lining as well as"/>
 <result pre="pro-inflammatory cytokines and chemokines rich milieu at the sites of" exact="infection" post="(30) (Figure 2). CCL2 (MCP-1) is a major chemokine"/>
 <result pre="CCL2 production, has shown reduced inflammation in synovial and skeletal" exact="muscle" post="tissues (82). Another study showed contrasting results in which"/>
 <result pre="CCR2−/− mice exhibited increased foot swelling and cartilage erosion upon" exact="CHIKV infection" post="(83). Macrophages are also known to be the reservoirs"/>
 <result pre="mice exhibited increased foot swelling and cartilage erosion upon CHIKV" exact="infection" post="(83). Macrophages are also known to be the reservoirs"/>
 <result pre="to be the reservoirs of CHIKV in later stages of" exact="infection" post="(24), which possibly plays an important role in prolonged"/>
 <result pre="neutrophil infiltration to the infected tissues (83). CCR2−/− mice upon" exact="CHIKV infection" post="showed enhanced arthritic symptoms without any significant change in"/>
 <result pre="infiltration to the infected tissues (83). CCR2−/− mice upon CHIKV" exact="infection" post="showed enhanced arthritic symptoms without any significant change in"/>
 <result pre="infected tissues (83). CCR2−/− mice upon CHIKV infection showed enhanced" exact="arthritic" post="symptoms without any significant change in viremia, as compared"/>
 <result pre="suggest that neutrophils are one of the key mediators of" exact="arthritic" post="symptoms and tissue damage in CHIKV infection by releasing"/>
 <result pre="the key mediators of arthritic symptoms and tissue damage in" exact="CHIKV infection" post="by releasing granules carrying antimicrobial molecules and producing reactive"/>
 <result pre="key mediators of arthritic symptoms and tissue damage in CHIKV" exact="infection" post="by releasing granules carrying antimicrobial molecules and producing reactive"/>
 <result pre="extracellular traps (NETs) through a process called NETosis. In vitro" exact="CHIKV infection" post="in neutrophils isolated from mice resulted in the formation"/>
 <result pre="traps (NETs) through a process called NETosis. In vitro CHIKV" exact="infection" post="in neutrophils isolated from mice resulted in the formation"/>
 <result pre="dependent mechanism. Also, the correlation of NETosis with susceptibility and" exact="viral" post="load has been shown in IFNAR−/− mice model and"/>
 <result pre="cells, which secrete high levels of IFN-I (87, 88). In" exact="CHIKV infection," post="the virus is sensed by pDCs in an indirect"/>
 <result pre="Figure 2 Immune cell infiltration in CHIKV infected tissues: the" exact="primary" post="target organs during CHIKV infection include liver, spleen, joints,"/>
 <result pre="infiltration in CHIKV infected tissues: the primary target organs during" exact="CHIKV infection" post="include liver, spleen, joints, and kidney. As the virus"/>
 <result pre="in CHIKV infected tissues: the primary target organs during CHIKV" exact="infection" post="include liver, spleen, joints, and kidney. As the virus"/>
 <result pre="kidney. As the virus is disseminated to these sites during" exact="acute" post="phase, it infects non-hematopoietic cells. Active viral replication within"/>
 <result pre="these sites during acute phase, it infects non-hematopoietic cells. Active" exact="viral" post="replication within these cells generate viral dsRNA and ssRNA"/>
 <result pre="infects non-hematopoietic cells. Active viral replication within these cells generate" exact="viral" post="dsRNA and ssRNA which is recognized by RLR and"/>
 <result pre="results in activation of IFN stimulating genes. The presence of" exact="viral" post="dsRNA and pro-inflammatory cytokines within these cells also activates"/>
 <result pre="other hand, OAS once triggered generates RNase L which degrades" exact="viral" post="RNA. In case of hematopoietic cells, endosomal TLRs recognize"/>
 <result pre="viral RNA. In case of hematopoietic cells, endosomal TLRs recognize" exact="viral" post="dsRNA. Downstream of TLR7, MyD88-IRAK-1-IRAF4-TRAF6 complex is recruited leading"/>
 <result pre="cells causing cellular infiltration. TLR, Toll-Like receptor; MyD88, myeloid differentiation" exact="primary" post="response 88; TRAF, tumor necrosis factor receptor (TNFR)-associated factors;"/>
 <result pre="TLR, Toll-Like receptor; MyD88, myeloid differentiation primary response 88; TRAF," exact="tumor" post="necrosis factor receptor (TNFR)-associated factors; IKB, nuclear factor of"/>
 <result pre="CD16. Specifically, NKG2C cells undergo rapid expansion during the early" exact="acute" post="phase of CHIKD and exert strong cytolytic response upon"/>
 <result pre="exert strong cytolytic response upon infected cells (90). As the" exact="disease" post="progresses in CHIKD, terminally differentiated NK cells mature into"/>
 <result pre="the number of mature NK cells peak in the early" exact="acute" post="phase (i.e., day 3 post-onset of symptoms) and their"/>
 <result pre="post-onset of symptoms) and their persistence is correlated with the" exact="viral" post="load. Additionally, the persistence of these cells is also"/>
 <result pre="Additionally, the persistence of these cells is also associated with" exact="chronic" post="CHIKD (90). In addition to the above mentioned pro-inflammatory"/>
 <result pre="(90). In addition to the above mentioned pro-inflammatory mechanisms, the" exact="acute" post="phase is also mediated by CD8+ T cells responses"/>
 <result pre="by CD8+ T cells responses at the early stages of" exact="infection" post="while in the later stages it's the CD4+ T"/>
 <result pre="CD8+ T cells infiltrate CHIKV-infected tissues during the course of" exact="infection" post="(93, 94). These infiltrating T cells are understandably involved"/>
 <result pre="CHIKV-infected tissues during the course of infection (93, 94). These" exact="infiltrating" post="T cells are understandably involved in mounting site-specific antiviral"/>
 <result pre="have recently been shown to contribute toward the pathogenesis during" exact="CHIKV infection" post="in mice without altering much of the viral titers"/>
 <result pre="recently been shown to contribute toward the pathogenesis during CHIKV" exact="infection" post="in mice without altering much of the viral titers"/>
 <result pre="during CHIKV infection in mice without altering much of the" exact="viral" post="titers along with IFN-γ production (95). During the acute"/>
 <result pre="the viral titers along with IFN-γ production (95). During the" exact="acute" post="phase, anti-CHIKV IgM could be detected in sera samples"/>
 <result pre="is mostly rare during the initial days (&amp;lt;4 days) of" exact="infection" post="(97). Several studies have also established a correlation between"/>
 <result pre="also established a correlation between antibodies response with cytokine levels," exact="viral" post="titres, and disease progression during the acute and chronic"/>
 <result pre="correlation between antibodies response with cytokine levels, viral titres, and" exact="disease" post="progression during the acute and chronic phases (97, 98)."/>
 <result pre="with cytokine levels, viral titres, and disease progression during the" exact="acute" post="and chronic phases (97, 98). Patients with high virus"/>
 <result pre="levels, viral titres, and disease progression during the acute and" exact="chronic" post="phases (97, 98). Patients with high virus titres in"/>
 <result pre="phases (97, 98). Patients with high virus titres in the" exact="acute" post="phase or viremic phase triggered the production of Anti-CHIKV"/>
 <result pre="arthralgia conditions whereas patients with low virus titres associated with" exact="chronic" post="arthralgia (99). This suggested that high virus titres in"/>
 <result pre="arthralgia (99). This suggested that high virus titres in the" exact="acute" post="phase seem to induce high titer of Anti-CHIKV antibodies"/>
 <result pre="to induce high titer of Anti-CHIKV antibodies which protect against" exact="chronic" post="stages of CHIKD (99). Additionally, CD4+ null mice showed"/>
 <result pre="chronic stages of CHIKD (99). Additionally, CD4+ null mice showed" exact="lower" post="levels of anti-CHIKV antibodies along with significantly reduced neutralizing"/>
 <result pre="of the target cells (102). Studies have reported that the" exact="peripheral" post="blood of acute and chronic CHIKD patients had no"/>
 <result pre="cells (102). Studies have reported that the peripheral blood of" exact="acute" post="and chronic CHIKD patients had no differences in the"/>
 <result pre="Studies have reported that the peripheral blood of acute and" exact="chronic" post="CHIKD patients had no differences in the percentage of"/>
 <result pre="T cells revealed increased CD8+ T cell activation in both" exact="acute" post="and chronic diseases (103). The study further observed that"/>
 <result pre="revealed increased CD8+ T cell activation in both acute and" exact="chronic" post="diseases (103). The study further observed that CD8+ T"/>
 <result pre="study further observed that CD8+ T lymphocytes in patients with" exact="acute" post="CHIKD have increased secretion of CD107A along with granzyme"/>
 <result pre="in mediating cytolytic killing of CHIKV infected cells during the" exact="acute" post="phase of CHIKD (103). Interestingly, the CD8+ T cells"/>
 <result pre="in the expression of granzyme and perforins in patients with" exact="chronic" post="disease in comparison to healthy controls (103). Such observations"/>
 <result pre="the expression of granzyme and perforins in patients with chronic" exact="disease" post="in comparison to healthy controls (103). Such observations point"/>
 <result pre="the post-acute phase of CHIKD. This phase is marked by" exact="complete" post="clearance of active CHIKV from the body by neutralizing"/>
 <result pre="antibodies in the blood and destruction of infected cells by" exact="infiltrating" post="NK cells, CD8+ T cells, and neutrophils. Detection of"/>
 <result pre="post clinical presentation. IgM antibodies could be detected during the" exact="acute" post="phase of infection, whereas IgG antibodies are detected in"/>
 <result pre="last for months (104–106). Titres of neutralizing antibodies during the" exact="acute" post="phase could predict the severity of CHIKD (97). Some"/>
 <result pre="improvement in their clinical state and deterioration occurs after a" exact="short" post="&quot;healing�? period (61). Also, a recent study using a"/>
 <result pre="a recent study using a C57BL/6J mice model has correlated" exact="viral" post="clearance and development of IgG antibodies with age. It"/>
 <result pre="and IgG titres were higher in 8-week-old mice during the" exact="acute" post="phase, whereas CHIKV clearance was not observed until post-acute"/>
 <result pre="antibodies, detection of anti-CHIKV IgG is mostly rare during the" exact="acute" post="phase of infection while detection occurs in the post-acute"/>
 <result pre="anti-CHIKV IgG is mostly rare during the acute phase of" exact="infection" post="while detection occurs in the post-acute phase and persists"/>
 <result pre="in the blood and synovial fluid is associated with severe" exact="chronic" post="CHIKD (109–111). IgG2c isotype is the major class of"/>
 <result pre="been reported in mice models as a therapeutic treatment against" exact="chikungunya" post="persistence (104, 112–118). In accordance with that, mice mutant"/>
 <result pre="Rag1−/− which lack B and T cells, leading to high" exact="viral" post="titres in various tissues, concluded that chikungunya infection persists"/>
 <result pre="leading to high viral titres in various tissues, concluded that" exact="chikungunya" post="infection persists in tissues that are controlled by adaptive"/>
 <result pre="to high viral titres in various tissues, concluded that chikungunya" exact="infection" post="persists in tissues that are controlled by adaptive immune"/>
 <result pre="blood (25). Similarly, administration of human monoclonal CHIKV-specific antibodies in" exact="chikungunya" post="infected rhesus monkeys led to inhibition of viral spread"/>
 <result pre="antibodies in chikungunya infected rhesus monkeys led to inhibition of" exact="viral" post="spread and inflammatory responses in various tissues like joints"/>
 <result pre="identified as the key factor responsible for CHIKV clearance (123)." exact="Disease" post="Resolution Chikungunya disease resolution is a combination of viral"/>
 <result pre="key factor responsible for CHIKV clearance (123). Disease Resolution Chikungunya" exact="disease" post="resolution is a combination of viral clearance from the"/>
 <result pre="(123). Disease Resolution Chikungunya disease resolution is a combination of" exact="viral" post="clearance from the host and resolution of inflammation, as"/>
 <result pre="response. As discussed in the earlier parts of the review," exact="viral" post="clearance in the circulatory system is led by neutralizing"/>
 <result pre="antibodies, and virus replicating in the tissues is tackled by" exact="infiltrating" post="pro-inflammatory cells like macrophages, CD8+ T cells, neutrophils, and"/>
 <result pre="T cells, neutrophils, and NK cells. The other arm of" exact="disease" post="resolution, resolution of inflammation, is a complex network of"/>
 <result pre="insight into the mechanism underneath the resolution of inflammation upon" exact="CHIKV infection." post="Also, RNA-seq analysis of feet and lymph nodes of"/>
 <result pre="infected mice highlighted granzyme A as a major promoter of" exact="arthritic" post="inflammation (135). An important feature that decides resolution of"/>
 <result pre="support the persistence of CHIKV in the system leading to" exact="chronic" post="disease. This hypothesis is supported by a study performed"/>
 <result pre="function of silencing of genes related to diseases (140), the" exact="viral infection" post="is an example of the complex interplay between viral"/>
 <result pre="of silencing of genes related to diseases (140), the viral" exact="infection" post="is an example of the complex interplay between viral"/>
 <result pre="viral infection is an example of the complex interplay between" exact="viral" post="RNA, endogenous miRNA, and host immune factors (141–144). A"/>
 <result pre="immune factors (141–144). A recent report suggested that CHIKV establishes" exact="infections" post="by regulating miRNA expression profile (145). miR15, miR-16, miR-17,"/>
 <result pre="miR-16, miR-17, let-7e, miR-125, miR-99, and miR-23a are altered during" exact="CHIKV infection" post="which indicates that these act as biomarkers in chikungunya"/>
 <result pre="miR-17, let-7e, miR-125, miR-99, and miR-23a are altered during CHIKV" exact="infection" post="which indicates that these act as biomarkers in chikungunya"/>
 <result pre="CHIKV infection which indicates that these act as biomarkers in" exact="chikungunya" post="infection (146). Target analysis suggests that targets of these"/>
 <result pre="infection which indicates that these act as biomarkers in chikungunya" exact="infection" post="(146). Target analysis suggests that targets of these miRNAs"/>
 <result pre="receptor interactions, and Fc gamma R-mediated phagocytosis (145). In addition," exact="CHIKV infection" post="in human synovial fibroblasts triggers the expression of miR-146a"/>
 <result pre="interactions, and Fc gamma R-mediated phagocytosis (145). In addition, CHIKV" exact="infection" post="in human synovial fibroblasts triggers the expression of miR-146a"/>
 <result pre="naïve Th cells differentiate into Th17 cells, but in the" exact="absence of" post="proinflammatory signals, TGF-β drives Treg differentiation (155–157). Th17 cell"/>
 <result pre="attracts neutrophils and hence promotes inflammation at the site of" exact="infection" post="(158). In contrast, Treg produces cytokines IL-10 and TGF-β,"/>
 <result pre="differentiating into Th17 cells (160), is a key player in" exact="arthritis" post="and rheumatism (161). Several studies have shown a significant"/>
 <result pre="susceptibility of the host is not only affected by the" exact="viral" post="sequence itself but is also controlled by multiple genes"/>
 <result pre="(172, 173). Bregs have been studied for their role in" exact="rheumatoid arthritis" post="(RA) and its regulation seems to be one of"/>
 <result pre="173). Bregs have been studied for their role in rheumatoid" exact="arthritis" post="(RA) and its regulation seems to be one of"/>
 <result pre="to be one of the key players that enhance RA" exact="disease" post="(174, 175). Considering that chikungunya-induced arthritis is an inflammatory"/>
 <result pre="players that enhance RA disease (174, 175). Considering that chikungunya-induced" exact="arthritis" post="is an inflammatory response triggered by the virus that"/>
 <result pre="by the virus that persists in joint tissues resulting in" exact="chronic" post="rheumatoid disease (1), it is possible that Bregs might"/>
 <result pre="virus that persists in joint tissues resulting in chronic rheumatoid" exact="disease" post="(1), it is possible that Bregs might be involved"/>
 <result pre="in the regulation of chikungunya-induced RA via modulating inflammatory responses." exact="Chronic" post="Phase In several CHIKD cases, inflammation causing joints pain"/>
 <result pre="for several months or years, resulting in symptoms similar to" exact="rheumatoid arthritis," post="and is termed as the chronic phase of CHIKD"/>
 <result pre="symptoms similar to rheumatoid arthritis, and is termed as the" exact="chronic" post="phase of CHIKD (176–178). Typically, the chronic phase is"/>
 <result pre="termed as the chronic phase of CHIKD (176–178). Typically, the" exact="chronic" post="phase is characterized by joint swelling, joint stiffness, arthralgia,"/>
 <result pre="of CHIKD (176–178). Typically, the chronic phase is characterized by" exact="joint swelling," post="joint stiffness, arthralgia, and tendonitis/tenosynovitis (119). Serologically, it marks"/>
 <result pre="a significant reduction of the virus as well as of" exact="viral" post="RNA, reduced osteoprotegerin, and increased IL-6 and RANKL (receptor"/>
 <result pre="of CHIKV RNA in the macrophages (24) and fibroblast during" exact="chronic" post="phase (183). Further, the viral dsRNA (intermediate stage during"/>
 <result pre="macrophages (24) and fibroblast during chronic phase (183). Further, the" exact="viral" post="dsRNA (intermediate stage during replication) found in the monocytes/macrophages"/>
 <result pre="as granules along the cell membrane in cells in persistent" exact="infection" post="(33), while in another study, CHIKV-capsid proteins were evident"/>
 <result pre="late as 60 days post-infection, suggesting the active translation of" exact="viral" post="proteins during the chronic phase of CHIKD (25). CD4+"/>
 <result pre="post-infection, suggesting the active translation of viral proteins during the" exact="chronic" post="phase of CHIKD (25). CD4+ and CD8+ T cells"/>
 <result pre="causing inflammation. Specifically, CD4+ T cells are majorly responsible for" exact="joint swelling" post="and inflammation and possibly mediate inflammatory pathways through CD4+"/>
 <result pre="joint links the abnormal T-cell response to bone damage in" exact="arthritis" post="(184, 185). One study found increased expression of CD95/CD95L"/>
 <result pre="CD8+ cells, although cells are nearly constant from healthy to" exact="acute" post="to chronic phase, the persistent exposure of antigens to"/>
 <result pre="although cells are nearly constant from healthy to acute to" exact="chronic" post="phase, the persistent exposure of antigens to CD8+ T"/>
 <result pre="be safely assumed that these cells stay activated through the" exact="chronic" post="phase, hence having a role in disease resolution and"/>
 <result pre="activated through the chronic phase, hence having a role in" exact="disease" post="resolution and chronicity. Furthermore, effective immune cell activation drives"/>
 <result pre="leading to T-cell exhaustion, and this may be linked to" exact="viral" post="persistence observed in the chronic phase (26). Additionally, the"/>
 <result pre="this may be linked to viral persistence observed in the" exact="chronic" post="phase (26). Additionally, the absence of CD8+ T cells"/>
 <result pre="viral persistence observed in the chronic phase (26). Additionally, the" exact="absence of" post="CD8+ T cells in synovial tissue may also be"/>
 <result pre="toward the persistence of CHIKV (26). Another hallmark of the" exact="chronic" post="phase is bone erosion and degradation of extracellular matrix"/>
 <result pre="bone erosion and degradation of extracellular matrix in joints, causing" exact="chronic" post="arthralgia in CHIKD patients. Key players of the mechanism"/>
 <result pre="(MMP) in chondrocytes that promote extracellular matrix degradation during the" exact="chronic" post="phase (189) (Figure 3). Figure 3 Chronic phase-CHIKV mediated"/>
 <result pre="degradation during the chronic phase (189) (Figure 3). Figure 3" exact="Chronic" post="phase-CHIKV mediated joint pathology: in the joints, osteoblast cells"/>
 <result pre="in the joints, osteoblast cells (Bone-forming cells) are susceptible to" exact="CHIKV infection" post="causing over-expression of IL-6 and RANKL and inhibition of"/>
 <result pre="the joints, osteoblast cells (Bone-forming cells) are susceptible to CHIKV" exact="infection" post="causing over-expression of IL-6 and RANKL and inhibition of"/>
 <result pre="secrete enhanced levels of RANKL, IL-6, IL-8, and (MCP-1), upon" exact="CHIKV infection" post="resulting in higher RANKL: OPG ratio, which favors osteoclast"/>
 <result pre="enhanced levels of RANKL, IL-6, IL-8, and (MCP-1), upon CHIKV" exact="infection" post="resulting in higher RANKL: OPG ratio, which favors osteoclast"/>
 <result pre="that may contain both the virus as well as the" exact="viral" post="antibodies that may affect the virus pathogenicity when delivered"/>
 <result pre="role of mosquito saliva is strikingly an understudied phenomenon in" exact="CHIKV infection." post="Does the mosquito saliva possess factors that can actively"/>
 <result pre="Does the mosquito saliva possess factors that can actively modulate" exact="viral" post="pathogenesis? Can these molecules be utilized for developing novel"/>
 <result pre="developing novel antiviral strategies? How exactly does the presence of" exact="viral" post="antibodies from previous bites affect CHIKV pathogenicity during the"/>
 <result pre="help in arriving on novel transmission blocking strategies. Once the" exact="infection" post="is established, the innate and adaptive host immunity plays"/>
 <result pre="host immunity plays definitive roles in the progression of the" exact="disease" post="that we know to be both protective as well"/>
 <result pre="its response. These responses decide the clinical presentation of the" exact="disease" post="at the febrile acute phase in terms of peak"/>
 <result pre="decide the clinical presentation of the disease at the febrile" exact="acute" post="phase in terms of peak viremia, small joint and"/>
 <result pre="viremia, small joint and large joint involvement, as well as" exact="disease" post="resolution during the post-acute phase. The current understanding of"/>
 <result pre="understanding of the subject suggests that arthritogenic symptoms in the" exact="acute" post="phase of CHIKD are primarily due to pro-inflammatory host"/>
 <result pre="responses that could lead to the possible association of severe" exact="chronic" post="cases with autoimmunity. Can we derive more knowledge regarding"/>
 <result pre="more knowledge regarding this association by looking into other similar" exact="autoimmune" post="disorders such as rheumatoid arthritis? Will employing animal models"/>
 <result pre="association by looking into other similar autoimmune disorders such as" exact="rheumatoid arthritis?" post="Will employing animal models specific to autoimmune disorders help"/>
 <result pre="such as rheumatoid arthritis? Will employing animal models specific to" exact="autoimmune" post="disorders help in answering some immunological questions pertaining to"/>
 <result pre="How well are we using the clinical evidence to understand" exact="disease" post="progression in the case of CHIKD? How do we"/>
 <result pre="on this information pertaining to inflammation specifically to alleviate the" exact="arthritic" post="phase? The resolution of CHIKD is not yet fully"/>
 <result pre="that have not been studied in the context of CHIKV" exact="chronic" post="infections. This review has strived to emphasize the various"/>
 <result pre="to emphasize the various immunological aspects that may lead to" exact="disease" post="resolution/progression in CHIKD and highlight the lacuna present currently"/>
 <result pre="The authors declare that the research was conducted in the" exact="absence of" post="any commercial or financial relationships that could be construed"/>
 <result pre="Nat Rev Rheumatol. (2012) 8:420. 10.1038/nrrheum.2012.6422565316 2.WahidBAliARafiqueSIdreesM. Global expansion of" exact="chikungunya" post="virus: mapping the 64-year history. Int J Infect Dis."/>
 <result pre="J Infect Dis. (2017) 58:69–76. 10.1016/j.ijid.2017.03.00628288924 3.PowersAMLogueCH. Changing patterns of" exact="chikungunya" post="virus: re-emergence of a zoonotic arbovirus. J Genrl Virol."/>
 <result pre="Lancet. (2014) 383:514. 10.1016/S0140-6736(14)60185-924506907 5.RaoTRCareyDEPavriKM. Preliminary isolation and identification of" exact="chikungunya" post="virus from cases of dengue-like illness in Madras city."/>
 <result pre="J Med Res. (1965) 53:689–93.5830402 6.SchuffeneckerIItemanIMichaultAMurriSFrangeulLVaneyCet al.. Genome microevolution of" exact="chikungunya" post="viruses causing the Indian Ocean outbreak. PLoS Med. (2006)"/>
 <result pre="Ocean outbreak. PLoS Med. (2006) 3:e263. 10.1371/journal.pmed.003026316700631 7.VazeilleMMoutaillerSCoudrierDRousseauxCKhunHHuerreMet al.. Two" exact="chikungunya" post="isolates from the outbreak of La Reunion (Indian Ocean)"/>
 <result pre="outbreak of La Reunion (Indian Ocean) exhibit different patterns of" exact="infection" post="in the mosquito, Aedes albopictus. PLoS ONE. (2007) 2:e1168."/>
 <result pre="PLoS ONE. (2007) 2:e1168. 10.1371/journal.pone.000116818000540 8.VazeilleMJeanninCMartinESchaffnerFAFaillouxB. Chikungunya: a risk for" exact="Mediterranean" post="countries?Acta Tropica. (2008) 105:200–2. 10.1016/j.actatropica.2007.09.00918005927 9.TsetsarkinKAVanlandinghamDLMcGeeCEHiggsS. A single mutation"/>
 <result pre="countries?Acta Tropica. (2008) 105:200–2. 10.1016/j.actatropica.2007.09.00918005927 9.TsetsarkinKAVanlandinghamDLMcGeeCEHiggsS. A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potential. PLoS Pathog."/>
 <result pre="Lancet Infect Dis. (2007) 7:319–27. 10.1016/S1473-3099(07)70107-X17448935 12.RobinsonMCAn epidemic of virus" exact="disease" post="in Southern Province, Tanganyika territory, in 1952–1953. Trans R"/>
 <result pre="La HarpeAChikungunya virus infection-A retrospective study of 107 cases. South" exact="African" post="Med J. (1983) 68:313–5. 14.BorgheriniGPoubeauPJossaumeAGouixACotteLMichaultAet al.. Persistent arthralgia associated"/>
 <result pre="Med J. (1983) 68:313–5. 14.BorgheriniGPoubeauPJossaumeAGouixACotteLMichaultAet al.. Persistent arthralgia associated with" exact="chikungunya" post="virus: a study of 88 adult patients on reunion"/>
 <result pre="Persistent arthralgia associated with chikungunya virus: a study of 88" exact="adult" post="patients on reunion island. Clin Infect Dis. (2008) 47:469–75."/>
 <result pre="Infect Dis. (2008) 47:469–75. 10.1086/59000318611153 15.JavelleERiberaADegasneIGaüzèreAMarimoutouCSimonF. Specific management of post-chikungunya" exact="rheumatic" post="disorders: a retrospective study of 159 cases in Reunion"/>
 <result pre="post-chikungunya rheumatic disorders: a retrospective study of 159 cases in" exact="Reunion Island" post="from 2006-2012. PLoS Neglect Trop D. (2015) 9:e0003603. 10.1371/journal.pntd.000360325760632"/>
 <result pre="16.TournebizePCharlinCLagrangeM. Neurological manifestations in chikungunya: about 23 cases collected in" exact="Reunion Island." post="Rev Neurol. (2009) 165:48–51. 10.1016/j.neurol.2008.06.00918835614 17.RampalMSMeenaH. Neurological complications in"/>
 <result pre="Island. Rev Neurol. (2009) 165:48–51. 10.1016/j.neurol.2008.06.00918835614 17.RampalMSMeenaH. Neurological complications in" exact="chikungunya" post="fever. J Assoc Physicians India. (2007) 55:765–9. Available online"/>
 <result pre="India. (2007) 55:765–9. Available online at: https://europepmc.org/article/MED/31312203#free-full-text18290551 18.BalavoineSPircherMHoenBHerrmann-StorckCNajioullahFMadeuxBet al.. Guillain–barré" exact="syndrome" post="and chikungunya: description of all cases diagnosed during the"/>
 <result pre="Med Hyg. (2017) 97:356–60. 10.4269/ajtmh.15-075328722564 19.MehtaRGerardinPde BritoCAASoaresCNFerreiraLBSolomonTThe neurological complications of" exact="chikungunya" post="virus: a systematic review. Rev Med Virol. (2018) 28:e197810.1002/rmv.197829671914"/>
 <result pre="Med Virol. (2018) 28:e197810.1002/rmv.197829671914 20.RenaultPSoletJLSissokoDBalleydierELarrieuSFilleulLet al.. A major epidemic of" exact="chikungunya" post="virus infection on Reunion Island, France, 2005-2006. Am J"/>
 <result pre="Virol. (2018) 28:e197810.1002/rmv.197829671914 20.RenaultPSoletJLSissokoDBalleydierELarrieuSFilleulLet al.. A major epidemic of chikungunya" exact="virus infection" post="on Reunion Island, France, 2005-2006. Am J Trop Med"/>
 <result pre="(2018) 28:e197810.1002/rmv.197829671914 20.RenaultPSoletJLSissokoDBalleydierELarrieuSFilleulLet al.. A major epidemic of chikungunya virus" exact="infection" post="on Reunion Island, France, 2005-2006. Am J Trop Med"/>
 <result pre="20.RenaultPSoletJLSissokoDBalleydierELarrieuSFilleulLet al.. A major epidemic of chikungunya virus infection on" exact="Reunion Island," post="France, 2005-2006. Am J Trop Med Hyg. (2007) 77:727–31."/>
 <result pre="10.4269/ajtmh.2007.77.72717978079 21.HsuCHCruz-LopezFTorresDVPerez-PadillaJLorenziODRiveraAet al.. Risk factors for hospitalization of patients with" exact="chikungunya" post="virus infection at sentinel hospitals in Puerto Rico. PLoS"/>
 <result pre="21.HsuCHCruz-LopezFTorresDVPerez-PadillaJLorenziODRiveraAet al.. Risk factors for hospitalization of patients with chikungunya" exact="virus infection" post="at sentinel hospitals in Puerto Rico. PLoS Neglect Trop"/>
 <result pre="al.. Risk factors for hospitalization of patients with chikungunya virus" exact="infection" post="at sentinel hospitals in Puerto Rico. PLoS Neglect Trop"/>
 <result pre="Trop D. (2019) 13:e0007084. 10.1371/journal.pntd.000708430640900 22.RamfulDCarbonnierMPasquetMBouhmaniBGhazouaniJNoormahomedTet al.. Mother-to-child transmission of" exact="chikungunya" post="virus infection. Pediatr Infect Dis J. (2007) 26:811–5. 10.1097/INF.0b013e3180616d4f17721376"/>
 <result pre="D. (2019) 13:e0007084. 10.1371/journal.pntd.000708430640900 22.RamfulDCarbonnierMPasquetMBouhmaniBGhazouaniJNoormahomedTet al.. Mother-to-child transmission of chikungunya" exact="virus infection." post="Pediatr Infect Dis J. (2007) 26:811–5. 10.1097/INF.0b013e3180616d4f17721376 23.GérardinPBarauGMichaultABintnerMRandrianaivoHChokerGet al.."/>
 <result pre="(2007) 26:811–5. 10.1097/INF.0b013e3180616d4f17721376 23.GérardinPBarauGMichaultABintnerMRandrianaivoHChokerGet al.. Multidisciplinary prospective study of mother-to-child" exact="chikungunya" post="virus infections on the island of La Reunion. PLoS"/>
 <result pre="10.1097/INF.0b013e3180616d4f17721376 23.GérardinPBarauGMichaultABintnerMRandrianaivoHChokerGet al.. Multidisciplinary prospective study of mother-to-child chikungunya virus" exact="infections" post="on the island of La Reunion. PLoS Med. (2008)"/>
 <result pre="La Reunion. PLoS Med. (2008) 5:e60. 10.1371/journal.pmed.005006018351797 24.LabadieKLarcherTJoubertCManniouiADelacheBBrochardPet al.. Chikungunya" exact="disease" post="in nonhuman primates involves long-term viral persistence in macrophages."/>
 <result pre="10.1371/journal.pmed.005006018351797 24.LabadieKLarcherTJoubertCManniouiADelacheBBrochardPet al.. Chikungunya disease in nonhuman primates involves long-term" exact="viral" post="persistence in macrophages. J Clin Invest. (2010) 120:894–906. 10.1172/JCI4010420179353"/>
 <result pre="in macrophages. J Clin Invest. (2010) 120:894–906. 10.1172/JCI4010420179353 25.PooYSRuddPAGardnerJWilsonJALarcherTColleAet al.." exact="Multiple" post="immune factors are involved in controlling acute and chronic"/>
 <result pre="10.1172/JCI4010420179353 25.PooYSRuddPAGardnerJWilsonJALarcherTColleAet al.. Multiple immune factors are involved in controlling" exact="acute" post="and chronic chikungunya virus infection. PLoS Neglect Trop Dis."/>
 <result pre="al.. Multiple immune factors are involved in controlling acute and" exact="chronic" post="chikungunya virus infection. PLoS Neglect Trop Dis. (2014) 8:e3354."/>
 <result pre="Multiple immune factors are involved in controlling acute and chronic" exact="chikungunya" post="virus infection. PLoS Neglect Trop Dis. (2014) 8:e3354. 10.1371/journal.pntd.000335425474568"/>
 <result pre="immune factors are involved in controlling acute and chronic chikungunya" exact="virus infection." post="PLoS Neglect Trop Dis. (2014) 8:e3354. 10.1371/journal.pntd.000335425474568 26.HoarauJJBandjeeMCJTrototPKDasTLi-Pat-YuenGDassaBet al.."/>
 <result pre="PLoS Neglect Trop Dis. (2014) 8:e3354. 10.1371/journal.pntd.000335425474568 26.HoarauJJBandjeeMCJTrototPKDasTLi-Pat-YuenGDassaBet al.. Persistent" exact="chronic" post="inflammation and infection by chikungunya arthritogenic alphavirus in spite"/>
 <result pre="Dis. (2014) 8:e3354. 10.1371/journal.pntd.000335425474568 26.HoarauJJBandjeeMCJTrototPKDasTLi-Pat-YuenGDassaBet al.. Persistent chronic inflammation and" exact="infection" post="by chikungunya arthritogenic alphavirus in spite of a robust"/>
 <result pre="8:e3354. 10.1371/journal.pntd.000335425474568 26.HoarauJJBandjeeMCJTrototPKDasTLi-Pat-YuenGDassaBet al.. Persistent chronic inflammation and infection by" exact="chikungunya" post="arthritogenic alphavirus in spite of a robust host immune"/>
 <result pre="85:606–20. 10.1128/JVI.00767-1020962078 28.AkahataWYangYAndersenHSunSHoldawayHAKongPet al.. A virus-like particle vaccine for epidemic" exact="chikungunya" post="virus protects nonhuman primates against infection. Nat Med. (2010)"/>
 <result pre="Nat Med. (2010) 16:334. 10.1038/nm.210520111039 29.CarpentierKSMorrisonTE. Innate immune control of" exact="alphavirus infection." post="Curr Opin Virol. (2018) 28:53–60. 10.1016/j.coviro.2017.11.00629175515 30.LongKMHeiseMT. Protective and"/>
 <result pre="Virol. (2018) 28:53–60. 10.1016/j.coviro.2017.11.00629175515 30.LongKMHeiseMT. Protective and pathogenic responses to" exact="chikungunya" post="virus infection. Curr Trop Med Rep. (2015) 2:13–21. 10.1007/s40475-015-0037-z26366337"/>
 <result pre="(2018) 28:53–60. 10.1016/j.coviro.2017.11.00629175515 30.LongKMHeiseMT. Protective and pathogenic responses to chikungunya" exact="virus infection." post="Curr Trop Med Rep. (2015) 2:13–21. 10.1007/s40475-015-0037-z26366337 31.GérardinPFianuAMichaultAMussardCBoussaïdKRollotOet al.."/>
 <result pre="Trop Med Rep. (2015) 2:13–21. 10.1007/s40475-015-0037-z26366337 31.GérardinPFianuAMichaultAMussardCBoussaïdKRollotOet al.. Predictors of" exact="chikungunya" post="rheumatism: a prognostic survey ancillary to the TELECHIK cohort"/>
 <result pre="rheumatism: a prognostic survey ancillary to the TELECHIK cohort study." exact="Arthritis" post="Res Ther. (2013) 15:R9. 10.1186/ar413723302155 32.HoarauJ-JGayFPelléOSamriAJaffar-BandjeeM-CGasquePet al.. Identical strength"/>
 <result pre="against E2, nsP1 and capsid CHIKV proteins in recovered and" exact="chronic" post="patients after the epidemics of 2005-2006 in La Reunion"/>
 <result pre="and chronic patients after the epidemics of 2005-2006 in La" exact="Reunion Island." post="PLoS ONE. (2013) 8:e84695. 10.1371/journal.pone.008469524376836 33.RemenyiRGaoYHughesRECurdAZothnerCPeckhamMet al.. Persistent replication"/>
 <result pre="ONE. (2013) 8:e84695. 10.1371/journal.pone.008469524376836 33.RemenyiRGaoYHughesRECurdAZothnerCPeckhamMet al.. Persistent replication of a" exact="chikungunya" post="virus replicon in human cells is associated with presence"/>
 <result pre="virus replicon in human cells is associated with presence of" exact="stable" post="cytoplasmic granules containing nonstructural protein 3. J Virol. (2018)"/>
 <result pre="10.1128/JVI.00477-1829875241 34.StaplesJEBreimanRFPowersAM. Chikungunya fever: an epidemiological review of a re-emerging" exact="infectious disease." post="Clin Infect Dis. (2009) 49:942–8. 10.1086/60549619663604 35.MohanAKiranDManoharICKumarDP. Epidemiology, clinical"/>
 <result pre="(2009) 49:942–8. 10.1086/60549619663604 35.MohanAKiranDManoharICKumarDP. Epidemiology, clinical manifestations, and diagnosis of" exact="chikungunya" post="fever: lessons learned from the re-emerging epidemic. Indian J"/>
 <result pre="55:54. 10.4103/0019-5154.6035520418981 36.TanabeISTanabeELSantosECMartinsWVAraújoIMCavalcanteMCet al.. Cellular and molecular immune response to" exact="chikungunya" post="virus infection. Front Cell Infect Microbiol. (2018) 8:345. 10.3389/fcimb.2018.0034530364124"/>
 <result pre="10.4103/0019-5154.6035520418981 36.TanabeISTanabeELSantosECMartinsWVAraújoIMCavalcanteMCet al.. Cellular and molecular immune response to chikungunya" exact="virus infection." post="Front Cell Infect Microbiol. (2018) 8:345. 10.3389/fcimb.2018.0034530364124 37.�?lvarez-ArgüellesMEAlbaSRPérezMRRiveiroJABGarcíaSMDiagnosis and"/>
 <result pre="Infect Microbiol. (2018) 8:345. 10.3389/fcimb.2018.0034530364124 37.�?lvarez-ArgüellesMEAlbaSRPérezMRRiveiroJABGarcíaSMDiagnosis and molecular characterization of" exact="chikungunya" post="virus infections. In: Rodriguez-Morales AJ, editor. Current Topics in"/>
 <result pre="10.1007/s40744-018-0121-730047016 39.BriantLDesprèsPChoumetVMisséD. Role of skin immune cells on the host" exact="susceptibility to" post="mosquito-borne viruses. Virology. (2014) 464:26–32. 10.1016/j.virol.2014.06.02325043586 40.StyerLMKentKAAlbrightRGBennettCJKramerLDBernardKA. Mosquitoes inoculate"/>
 <result pre="44.LongKMFerrisMTWhitmoreACMontgomerySAThurlowLRMcGeeCEet al.. γδ T cells play a protective role in" exact="chikungunya" post="virus-induced disease. J Virol. (2016) 90:433–43. 10.1128/JVI.02159-1526491151 45.FuYXRoarkCEKellyKDrevetsDCampbellPO'BrienRet al.."/>
 <result pre="46.SouzaDCDCooperAMFrankAAMazzaccaroRJBloomBROrmeIM. An anti-inflammatory role for gamma delta T lymphocytes in" exact="acquired" post="immunity to Mycobacterium tuberculosis. J Immunol. (1997) 158:1217–21.9013962 47.PingenMBrydenSRPondevilleESchnettlerEKohlAMeritsAet"/>
 <result pre="mosquito salivary protein D7 enhances mortality from subsequent West Nile" exact="virus infection" post="via mosquito bite. PLoS Neglect Trop Dis. (2012) 6:e1935."/>
 <result pre="salivary protein D7 enhances mortality from subsequent West Nile virus" exact="infection" post="via mosquito bite. PLoS Neglect Trop Dis. (2012) 6:e1935."/>
 <result pre="(2012) 6:e1935. 10.1371/journal.pntd.000193523236530 49.PingenMSchmidMAHarrisEMcKimmieCS. Mosquito biting modulates skin response to" exact="virus infection." post="Trends Parasitol. (2017) 33:645–57. 10.1016/j.pt.2017.04.00328495485 50.SchneiderBSHiggsS. The enhancement of"/>
 <result pre="(2017) 33:645–57. 10.1016/j.pt.2017.04.00328495485 50.SchneiderBSHiggsS. The enhancement of arbovirus transmission and" exact="disease" post="by mosquito saliva is associated with modulation of the"/>
 <result pre="102:400–8. 10.1016/j.trstmh.2008.01.02418342898 51.StyerLMLimPYLouieKLAlbrightRGKramerLDBernardKA. Mosquito saliva causes enhancement of West Nile" exact="virus infection" post="in mice. J Virol. (2011) 85:1517–27. 10.1128/JVI.01112-1021147918 52.SchneiderBSSoongLZeidnerNSHiggsS. Aedes"/>
 <result pre="10.1016/j.trstmh.2008.01.02418342898 51.StyerLMLimPYLouieKLAlbrightRGKramerLDBernardKA. Mosquito saliva causes enhancement of West Nile virus" exact="infection" post="in mice. J Virol. (2011) 85:1517–27. 10.1128/JVI.01112-1021147918 52.SchneiderBSSoongLZeidnerNSHiggsS. Aedes"/>
 <result pre="in mice. J Virol. (2011) 85:1517–27. 10.1128/JVI.01112-1021147918 52.SchneiderBSSoongLZeidnerNSHiggsS. Aedes aegypti" exact="salivary gland" post="extracts modulate anti-viral and TH1/TH2 cytokine responses to sindbis"/>
 <result pre="gland extracts modulate anti-viral and TH1/TH2 cytokine responses to sindbis" exact="virus infection." post="Viral Immunol. (2004) 17:565–73. 10.1089/vim.2004.17.56515671753 53.ThangamaniSHiggsSZieglerSVanlandinghamDTeshRWikelS. Host immune response"/>
 <result pre="modulate anti-viral and TH1/TH2 cytokine responses to sindbis virus infection." exact="Viral" post="Immunol. (2004) 17:565–73. 10.1089/vim.2004.17.56515671753 53.ThangamaniSHiggsSZieglerSVanlandinghamDTeshRWikelS. Host immune response to"/>
 <result pre="Immunol. (2004) 17:565–73. 10.1089/vim.2004.17.56515671753 53.ThangamaniSHiggsSZieglerSVanlandinghamDTeshRWikelS. Host immune response to mosquito-transmitted" exact="chikungunya" post="virus differs from that elicited by needle inoculated virus."/>
 <result pre="10.1371/journal.pone.001213720711354 54.McCrackenMChristoffersonRGraspergeBCalvoEChisenhallDMoresC. Aedes aegypti salivary protein aegyptin co-inoculation modulates dengue" exact="virus infection" post="in the vertebrate host. Virology. (2014) 468:133–39. 10.1016/j.virol.2014.07.01925173089 55.HenriqueMONetoLSAssisJBBarrosMSCapurroMLLepiqueAPet"/>
 <result pre="54.McCrackenMChristoffersonRGraspergeBCalvoEChisenhallDMoresC. Aedes aegypti salivary protein aegyptin co-inoculation modulates dengue virus" exact="infection" post="in the vertebrate host. Virology. (2014) 468:133–39. 10.1016/j.virol.2014.07.01925173089 55.HenriqueMONetoLSAssisJBBarrosMSCapurroMLLepiqueAPet"/>
 <result pre="inoculation site. Sci Transl Med. (2020) 12:eaax2421. 10.1126/scitranslmed.aax242131969486 57.SchilteCCoudercTChretienFSourisseauMGangneuxNGuivel-BenhassineFet al.." exact="Type I" post="IFN controls chikungunya virus via its action on nonhematopoietic"/>
 <result pre="Med. (2020) 12:eaax2421. 10.1126/scitranslmed.aax242131969486 57.SchilteCCoudercTChretienFSourisseauMGangneuxNGuivel-BenhassineFet al.. Type I IFN controls" exact="chikungunya" post="virus via its action on nonhematopoietic cells. J Exp"/>
 <result pre="J Exp Med. (2010) 207:429–42. 10.1084/jem.2009085120123960 58.HarrisonVBinnLRandallR. Comparative immunogenicities of" exact="chikungunya" post="vaccines prepared in avian and mammalian tissues. Am J"/>
 <result pre="Med Hyg. (1967) 16:786–91. 10.4269/ajtmh.1967.16.7864965219 59.SchwartzOAlbertML. Biology and pathogenesis of" exact="chikungunya" post="virus. Nat Rev Microbiol. (2010) 8:491. 10.1038/nrmicro236820551973 60.JinJGalaz-MontoyaJGShermanMBSunSYGoldsmithCSO'TooleETet al.."/>
 <result pre="Rev Microbiol. (2010) 8:491. 10.1038/nrmicro236820551973 60.JinJGalaz-MontoyaJGShermanMBSunSYGoldsmithCSO'TooleETet al.. Neutralizing antibodies inhibit" exact="chikungunya" post="virus budding at the plasma membrane. Cell Host Microbe."/>
 <result pre="Oswaldo Cruz. (2017) 112:523–31. 10.1590/0074-0276017004428767976 62.MarquesDLDuarteALBPRanzolinADantasATCavalcantiNGGonçalvesSGet al.. Recommendations of the" exact="Brazilian" post="Society of Rheumatology for diagnosis and treatment of chikungunya"/>
 <result pre="the Brazilian Society of Rheumatology for diagnosis and treatment of" exact="chikungunya" post="fever. Part 1-Diagnosis and special situations. Rev Bras Reumatol"/>
 <result pre="Reumatol Engl Ed. (2017) 57:s421–37. 10.1016/j.rbre.2017.05.00628751131 63.HabjanMPichlmairA. Cytoplasmic sensing of" exact="viral" post="nucleic acids. Curr Opin Virol. (2015) 11:31–7. 10.1016/j.coviro.2015.01.01225668758 64.JensenSThomsenAR."/>
 <result pre="(2012) 86:2900–10. 10.1128/JVI.05738-1122258243 65.ChenWFooSSZaidATengTSHerreroLJWolfSet al.. Specific inhibition of NLRP3 in" exact="chikungunya" post="disease reveals a role for inflammasomes in alphavirus-induced inflammation."/>
 <result pre="86:2900–10. 10.1128/JVI.05738-1122258243 65.ChenWFooSSZaidATengTSHerreroLJWolfSet al.. Specific inhibition of NLRP3 in chikungunya" exact="disease" post="reveals a role for inflammasomes in alphavirus-induced inflammation. Nat"/>
 <result pre="10.1038/s41564-017-0015-428848230 66.EkchariyawatPHamelRBernardEWichitSSurasombatpattanaPTalignaniLet al.. Inflammasome signaling pathways exert antiviral effect against" exact="chikungunya" post="virus in human dermal fibroblasts. Infect Genet Evol. (2015)"/>
 <result pre="Evol. (2015) 32:401–8. 10.1016/j.meegid.2015.03.02525847693 67.OlagnierDScholteFEChiangCAlbulescuICNicholsCHeZet al.. Inhibition of dengue and" exact="chikungunya" post="virus infections by RIG-I-mediated type I interferon-independent stimulation of"/>
 <result pre="32:401–8. 10.1016/j.meegid.2015.03.02525847693 67.OlagnierDScholteFEChiangCAlbulescuICNicholsCHeZet al.. Inhibition of dengue and chikungunya virus" exact="infections" post="by RIG-I-mediated type I interferon-independent stimulation of the innate"/>
 <result pre="al.. Inhibition of dengue and chikungunya virus infections by RIG-I-mediated" exact="type I" post="interferon-independent stimulation of the innate antiviral response. J Virol."/>
 <result pre="68.PriyaRPatroIParidaM. TLR3 mediated innate immune response in mice brain following" exact="infection" post="with chikungunya virus. Virus Res. (2014) 189:194–205. 10.1016/j.virusres.2014.05.01024905288 69.PrykeKMAbrahamJSaliTMGallBJArcherILiuAet"/>
 <result pre="mediated innate immune response in mice brain following infection with" exact="chikungunya" post="virus. Virus Res. (2014) 189:194–205. 10.1016/j.virusres.2014.05.01024905288 69.PrykeKMAbrahamJSaliTMGallBJArcherILiuAet al.. A"/>
 <result pre="70.RuddPAWilsonJGardnerJLarcherTBabaritCLeTTet al.. Interferon response factors 3 and 7 protect against" exact="chikungunya" post="virus hemorrhagic fever and shock. J Virol. (2012) 86:9888–98."/>
 <result pre="shock. J Virol. (2012) 86:9888–98. 10.1128/JVI.00956-1222761364 71.TengTSFooSSimamartaDLumFMTeoTHLullaAet al.. Viperin restricts" exact="chikungunya" post="virus replication and pathology. J Clin Invest. (2012) 122:4447–60."/>
 <result pre="Clin Invest. (2012) 122:4447–60. 10.1172/JCI6312023160199 72.SourisseauMSchilteCCasartelliNTrouilletCGuivel-BenhassineFRudnickaDet al.. Characterization of reemerging" exact="chikungunya" post="virus. PLoS Pathog. (2007) 3:e89. 10.1371/journal.ppat.003008917604450 73.WikanNSakoonwatanyooPUbolSYoksanSSmithDR. Chikungunya virus"/>
 <result pre="of reemerging chikungunya virus. PLoS Pathog. (2007) 3:e89. 10.1371/journal.ppat.003008917604450 73.WikanNSakoonwatanyooPUbolSYoksanSSmithDR." exact="Chikungunya virus infection" post="of cell lines: analysis of the East, Central and"/>
 <result pre="reemerging chikungunya virus. PLoS Pathog. (2007) 3:e89. 10.1371/journal.ppat.003008917604450 73.WikanNSakoonwatanyooPUbolSYoksanSSmithDR. Chikungunya" exact="virus infection" post="of cell lines: analysis of the East, Central and"/>
 <result pre="chikungunya virus. PLoS Pathog. (2007) 3:e89. 10.1371/journal.ppat.003008917604450 73.WikanNSakoonwatanyooPUbolSYoksanSSmithDR. Chikungunya virus" exact="infection" post="of cell lines: analysis of the East, Central and"/>
 <result pre="Chikungunya virus infection of cell lines: analysis of the East," exact="Central" post="and South African lineage. PLoS ONE. (2012) 7:e31102. 10.1371/journal.pone.003110222299053"/>
 <result pre="of cell lines: analysis of the East, Central and South" exact="African" post="lineage. PLoS ONE. (2012) 7:e31102. 10.1371/journal.pone.003110222299053 74.Krejbich-TrototPGayBLi-Pat-YuenGHoarauJJJaffar-BandjeeMCBriantLet al.. Chikungunya"/>
 <result pre="10.1371/journal.pone.003110222299053 74.Krejbich-TrototPGayBLi-Pat-YuenGHoarauJJJaffar-BandjeeMCBriantLet al.. Chikungunya triggers an autophagic process which promotes" exact="viral" post="replication. Virol J. (2011) 8:432. 10.1186/1743-422X-8-43221902836 75.HerZMalleretBChanMOngEKWongS-CKwekDJet al.. Active"/>
 <result pre="viral replication. Virol J. (2011) 8:432. 10.1186/1743-422X-8-43221902836 75.HerZMalleretBChanMOngEKWongS-CKwekDJet al.. Active" exact="infection" post="of human blood monocytes by chikungunya virus triggers an"/>
 <result pre="10.1186/1743-422X-8-43221902836 75.HerZMalleretBChanMOngEKWongS-CKwekDJet al.. Active infection of human blood monocytes by" exact="chikungunya" post="virus triggers an innate immune response. J Immunol. (2010)"/>
 <result pre="172:5656–63. 10.4049/jimmunol.172.9.565615100310 77.Dupuis-MaguiragaLNoretMBrunSLe GrandRGrasGRoquesP. Chikungunya disease: infection-associated markers from the" exact="acute" post="to the chronic phase of arbovirus-induced arthralgia. PLoS Negl"/>
 <result pre="GrandRGrasGRoquesP. Chikungunya disease: infection-associated markers from the acute to the" exact="chronic" post="phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis. (2012)"/>
 <result pre="6:e1446. 10.1371/journal.pntd.000144622479654 78.CushingSDBerlinerJAValenteAJTerritoMCNavabMParhamiFet al.. Minimally modified low density lipoprotein induces" exact="monocyte" post="chemotactic protein 1 in human endothelial cells and smooth"/>
 <result pre="monocyte chemotactic protein 1 in human endothelial cells and smooth" exact="muscle" post="cells. Proc Natl Acad Sci USA. (1990) 87:5134–8. 10.1073/pnas.87.13.51341695010"/>
 <result pre="cells. Proc Natl Acad Sci USA. (1990) 87:5134–8. 10.1073/pnas.87.13.51341695010 79.StandifordTJKunkelSLPhanSHRollinsBJStrieterRM." exact="Alveolar" post="macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human"/>
 <result pre="Sci USA. (1990) 87:5134–8. 10.1073/pnas.87.13.51341695010 79.StandifordTJKunkelSLPhanSHRollinsBJStrieterRM. Alveolar macrophage-derived cytokines induce" exact="monocyte" post="chemoattractant protein-1 expression from human pulmonary type II-like epithelial"/>
 <result pre="Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human" exact="pulmonary" post="type II-like epithelial cells. J Biol Chem. (1991) 266:9912–8.2033076"/>
 <result pre="induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like" exact="epithelial" post="cells. J Biol Chem. (1991) 266:9912–8.2033076 80.BrownZStrieterRMNeildGHThompsonRCKunkelSLWestwickJ. IL-1 receptor"/>
 <result pre="J Biol Chem. (1991) 266:9912–8.2033076 80.BrownZStrieterRMNeildGHThompsonRCKunkelSLWestwickJ. IL-1 receptor antagonist inhibits" exact="monocyte" post="chemotactic peptide 1 generation by human mesangial cells. Kidney"/>
 <result pre="inhibits monocyte chemotactic peptide 1 generation by human mesangial cells." exact="Kidney" post="Int. (1992) 42:95–101. 10.1038/ki.1992.2661386129 81.BarnaBPPettayJBarnettGHZhouPIwasakiKEstesML. Regulation of monocyte chemoattractant"/>
 <result pre="mesangial cells. Kidney Int. (1992) 42:95–101. 10.1038/ki.1992.2661386129 81.BarnaBPPettayJBarnettGHZhouPIwasakiKEstesML. Regulation of" exact="monocyte" post="chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is"/>
 <result pre="42:95–101. 10.1038/ki.1992.2661386129 81.BarnaBPPettayJBarnettGHZhouPIwasakiKEstesML. Regulation of monocyte chemoattractant protein-1 expression in" exact="adult" post="human non-neoplastic astrocytes is sensitive to tumor necrosis factor"/>
 <result pre="protein-1 expression in adult human non-neoplastic astrocytes is sensitive to" exact="tumor" post="necrosis factor (TNF) or antibody to the 55-kDa TNF"/>
 <result pre="TNF receptor. J Neuroimmunol. (1994) 50:101–7. 10.1016/0165-5728(94)90220-88300851 82.RulliNERolphMSSrikiatkhachornAAnantapreechaSGuglielmottiAMahalingamS. Protection from" exact="arthritis" post="and myositis in a mouse model of acute chikungunya"/>
 <result pre="J Neuroimmunol. (1994) 50:101–7. 10.1016/0165-5728(94)90220-88300851 82.RulliNERolphMSSrikiatkhachornAAnantapreechaSGuglielmottiAMahalingamS. Protection from arthritis and" exact="myositis" post="in a mouse model of acute chikungunya virus disease"/>
 <result pre="Protection from arthritis and myositis in a mouse model of" exact="acute" post="chikungunya virus disease by bindarit, an inhibitor of monocyte"/>
 <result pre="from arthritis and myositis in a mouse model of acute" exact="chikungunya" post="virus disease by bindarit, an inhibitor of monocyte chemotactic"/>
 <result pre="and myositis in a mouse model of acute chikungunya virus" exact="disease" post="by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis."/>
 <result pre="of acute chikungunya virus disease by bindarit, an inhibitor of" exact="monocyte" post="chemotactic protein-1 synthesis. J Infect Dis. (2011) 204:1026–30. 10.1093/infdis/jir47021881117"/>
 <result pre="synthesis. J Infect Dis. (2011) 204:1026–30. 10.1093/infdis/jir47021881117 83.PooYSNakayaHGardnerJLarcherTSchroderWALeTTet al.. CCR2" exact="deficiency" post="promotes exacerbated chronic erosive neutrophil-dominated chikungunya virus arthritis. J"/>
 <result pre="Dis. (2011) 204:1026–30. 10.1093/infdis/jir47021881117 83.PooYSNakayaHGardnerJLarcherTSchroderWALeTTet al.. CCR2 deficiency promotes exacerbated" exact="chronic" post="erosive neutrophil-dominated chikungunya virus arthritis. J Virol. (2014) 88:6862–72."/>
 <result pre="10.1093/infdis/jir47021881117 83.PooYSNakayaHGardnerJLarcherTSchroderWALeTTet al.. CCR2 deficiency promotes exacerbated chronic erosive neutrophil-dominated" exact="chikungunya" post="virus arthritis. J Virol. (2014) 88:6862–72. 10.1128/JVI.03364-1324696480 84.SchönrichGRafteryMJ. Neutrophil"/>
 <result pre="85.BianZGuoYHaBZenKLiuY. Regulation of the inflammatory response: enhancing neutrophil infiltration under" exact="chronic" post="inflammatory conditions. J Immunol. (2012) 188:844–53. 10.4049/jimmunol.110173622156344 86.HirokiCHToller-KawahisaJEFumagalliMJColónDFFigueiredoLTFonsecaBAet al.."/>
 <result pre="(2012) 188:844–53. 10.4049/jimmunol.110173622156344 86.HirokiCHToller-KawahisaJEFumagalliMJColónDFFigueiredoLTFonsecaBAet al.. Neutrophil extracellular traps effectively control" exact="acute" post="chikungunya virus infection. Front Immunol. (2019) 10:3108. 10.3389/fimmu.2019.0310832082301 87.LandeRGangulyDFacchinettiVFrascaLConradCGregorioJet"/>
 <result pre="188:844–53. 10.4049/jimmunol.110173622156344 86.HirokiCHToller-KawahisaJEFumagalliMJColónDFFigueiredoLTFonsecaBAet al.. Neutrophil extracellular traps effectively control acute" exact="chikungunya" post="virus infection. Front Immunol. (2019) 10:3108. 10.3389/fimmu.2019.0310832082301 87.LandeRGangulyDFacchinettiVFrascaLConradCGregorioJet al.."/>
 <result pre="10.4049/jimmunol.110173622156344 86.HirokiCHToller-KawahisaJEFumagalliMJColónDFFigueiredoLTFonsecaBAet al.. Neutrophil extracellular traps effectively control acute chikungunya" exact="virus infection." post="Front Immunol. (2019) 10:3108. 10.3389/fimmu.2019.0310832082301 87.LandeRGangulyDFacchinettiVFrascaLConradCGregorioJet al.. Neutrophils activate"/>
 <result pre="Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA–peptide complexes in" exact="systemic" post="lupus erythematosus. Sci Transl Med. (2011) 3:73ra19. 10.1126/scitranslmed.300118021389263 88.SwieckiMColonnaM."/>
 <result pre="activate plasmacytoid dendritic cells by releasing self-DNA–peptide complexes in systemic" exact="lupus erythematosus." post="Sci Transl Med. (2011) 3:73ra19. 10.1126/scitranslmed.300118021389263 88.SwieckiMColonnaM. The multifaceted"/>
 <result pre="15:471. 10.1038/nri386526160613 89.WebsterBWernekeSWZafirovaBThisSColéonSDecembreEet al.. Plasmacytoid dendritic cells control dengue and" exact="chikungunya" post="virus infections via IRF7-regulated interferon responses. Elife. (2018) 7:e34273."/>
 <result pre="89.WebsterBWernekeSWZafirovaBThisSColéonSDecembreEet al.. Plasmacytoid dendritic cells control dengue and chikungunya virus" exact="infections" post="via IRF7-regulated interferon responses. Elife. (2018) 7:e34273. 10.7554/eLife.3427329914621 90.PetitdemangeCBecquartPWauquierNBeziatVDebrePLeroyEMet"/>
 <result pre="7:e34273. 10.7554/eLife.3427329914621 90.PetitdemangeCBecquartPWauquierNBeziatVDebrePLeroyEMet al.. Unconventional repertoire profile is imprinted during" exact="acute" post="chikungunya infection for natural killer cells polarization toward cytotoxicity."/>
 <result pre="10.7554/eLife.3427329914621 90.PetitdemangeCBecquartPWauquierNBeziatVDebrePLeroyEMet al.. Unconventional repertoire profile is imprinted during acute" exact="chikungunya" post="infection for natural killer cells polarization toward cytotoxicity. PLoS"/>
 <result pre="90.PetitdemangeCBecquartPWauquierNBeziatVDebrePLeroyEMet al.. Unconventional repertoire profile is imprinted during acute chikungunya" exact="infection" post="for natural killer cells polarization toward cytotoxicity. PLoS Pathog."/>
 <result pre="relevance to disease. Front Immunol. (2013) 4:422. 10.3389/fimmu.2013.0042224367364 92.WauquierNBecquartPNkogheDPadillaCNdjoyi-MbiguinoALeroyEM. The" exact="acute" post="phase of chikungunya virus infection in humans is associated"/>
 <result pre="Front Immunol. (2013) 4:422. 10.3389/fimmu.2013.0042224367364 92.WauquierNBecquartPNkogheDPadillaCNdjoyi-MbiguinoALeroyEM. The acute phase of" exact="chikungunya" post="virus infection in humans is associated with strong innate"/>
 <result pre="Immunol. (2013) 4:422. 10.3389/fimmu.2013.0042224367364 92.WauquierNBecquartPNkogheDPadillaCNdjoyi-MbiguinoALeroyEM. The acute phase of chikungunya" exact="virus infection" post="in humans is associated with strong innate immunity and"/>
 <result pre="(2013) 4:422. 10.3389/fimmu.2013.0042224367364 92.WauquierNBecquartPNkogheDPadillaCNdjoyi-MbiguinoALeroyEM. The acute phase of chikungunya virus" exact="infection" post="in humans is associated with strong innate immunity and"/>
 <result pre="J Infect Dis. (2011) 204:115–23. 10.1093/infdis/jiq00621628665 93.GardnerJAnrakuILeTTLarcherTMajorLRoquesPet al.. Chikungunya virus" exact="arthritis" post="in adult wild-type mice. J Virol. (2010) 84:8021–32. 10.1128/JVI.02603-0920519386"/>
 <result pre="Dis. (2011) 204:115–23. 10.1093/infdis/jiq00621628665 93.GardnerJAnrakuILeTTLarcherTMajorLRoquesPet al.. Chikungunya virus arthritis in" exact="adult" post="wild-type mice. J Virol. (2010) 84:8021–32. 10.1128/JVI.02603-0920519386 94.MorrisonTEOkoLMontgomerySAWhitmoreACLotsteinARGunnBMet al.."/>
 <result pre="Virol. (2010) 84:8021–32. 10.1128/JVI.02603-0920519386 94.MorrisonTEOkoLMontgomerySAWhitmoreACLotsteinARGunnBMet al.. A mouse model of" exact="chikungunya" post="virus–induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis,"/>
 <result pre="95.TeoTHLumMClaserCLullaVLullaAMeritsAet al.. A pathogenic role for CD4+ T cells during" exact="chikungunya" post="virus infection in mice. J Immunol. (2013) 190:259–69. 10.4049/jimmunol.120217723209328"/>
 <result pre="al.. A pathogenic role for CD4+ T cells during chikungunya" exact="virus infection" post="in mice. J Immunol. (2013) 190:259–69. 10.4049/jimmunol.120217723209328 96.PanningMGrywnaKVan EsbroeckMEmmerichPDrostenC."/>
 <result pre="A pathogenic role for CD4+ T cells during chikungunya virus" exact="infection" post="in mice. J Immunol. (2013) 190:259–69. 10.4049/jimmunol.120217723209328 96.PanningMGrywnaKVan EsbroeckMEmmerichPDrostenC."/>
 <result pre="infection in mice. J Immunol. (2013) 190:259–69. 10.4049/jimmunol.120217723209328 96.PanningMGrywnaKVan EsbroeckMEmmerichPDrostenC." exact="Chikungunya fever" post="in travelers returning to Europe from the Indian Ocean"/>
 <result pre="10.3201/eid1403.07090618325256 97.JainJNayakKTanwarNGaindRGuptaBShastriJet al.. Clinical, serological, and virological analysis of 572" exact="chikungunya" post="patients from 2010 to 2013 in India. Clin Infect"/>
 <result pre="(2017) 65:133–40. 10.1093/cid/cix28328379375 98.KamYWLumFMTeoTHLeeWWSimarmataDHarjantoSet al.. Early neutralizing IgG response to" exact="chikungunya" post="virus in infected patients targets a dominant linear epitope"/>
 <result pre="Early appearance of neutralizing immunoglobulin G3 antibodies is associated with" exact="chikungunya" post="virus clearance and long-term clinical protection. J Infect Dis."/>
 <result pre="100.LumMTeoHLeeWWKamWRéniaLNgLF. An essential role of antibodies in the control of" exact="chikungunya" post="virus infection. J Immunol. (2013) 190:6295–302. 10.4049/jimmunol.130030423670192 101.FoxJMDiamondMS. Immune-mediated"/>
 <result pre="An essential role of antibodies in the control of chikungunya" exact="virus infection." post="J Immunol. (2013) 190:6295–302. 10.4049/jimmunol.130030423670192 101.FoxJMDiamondMS. Immune-mediated protection and"/>
 <result pre="Immunol. (2013) 190:6295–302. 10.4049/jimmunol.130030423670192 101.FoxJMDiamondMS. Immune-mediated protection and pathogenesis of" exact="chikungunya" post="virus. J Immunol. (2016) 197:4210–8. 10.4049/jimmunol.160142627864552 102.WolintPBettsMRKoupRAOxeniusAImmediate cytotoxicity but"/>
 <result pre="(2004) 199:925–36. 10.1084/jem.2003179915051762 103.DiasNSGoisBMLimaVSGuerra-GomesICAraujoMGGomesASet al.. Human CD8 T-cell activation in" exact="acute" post="and chronic chikungunya infection. Immunology. (2018) 155:499–504. 10.1111/imm.1299230099739 104.CoudercTKhandoudiNGrandadamMVisseCGangneuxNBagotSet"/>
 <result pre="10.1084/jem.2003179915051762 103.DiasNSGoisBMLimaVSGuerra-GomesICAraujoMGGomesASet al.. Human CD8 T-cell activation in acute and" exact="chronic" post="chikungunya infection. Immunology. (2018) 155:499–504. 10.1111/imm.1299230099739 104.CoudercTKhandoudiNGrandadamMVisseCGangneuxNBagotSet al.. Prophylaxis"/>
 <result pre="103.DiasNSGoisBMLimaVSGuerra-GomesICAraujoMGGomesASet al.. Human CD8 T-cell activation in acute and chronic" exact="chikungunya" post="infection. Immunology. (2018) 155:499–504. 10.1111/imm.1299230099739 104.CoudercTKhandoudiNGrandadamMVisseCGangneuxNBagotSet al.. Prophylaxis and"/>
 <result pre="Immunology. (2018) 155:499–504. 10.1111/imm.1299230099739 104.CoudercTKhandoudiNGrandadamMVisseCGangneuxNBagotSet al.. Prophylaxis and therapy for" exact="chikungunya" post="virus infection. J Infect Dis. (2009) 200:516–23. 10.1086/60038119572805 105.TandaleBVSathePSArankalleVAWadiaRSKulkarniRShahSVet"/>
 <result pre="(2018) 155:499–504. 10.1111/imm.1299230099739 104.CoudercTKhandoudiNGrandadamMVisseCGangneuxNBagotSet al.. Prophylaxis and therapy for chikungunya" exact="virus infection." post="J Infect Dis. (2009) 200:516–23. 10.1086/60038119572805 105.TandaleBVSathePSArankalleVAWadiaRSKulkarniRShahSVet al.. Systemic"/>
 <result pre="virus infection. J Infect Dis. (2009) 200:516–23. 10.1086/60038119572805 105.TandaleBVSathePSArankalleVAWadiaRSKulkarniRShahSVet al.." exact="Systemic" post="involvements and fatalities during chikungunya epidemic in India, (2006)."/>
 <result pre="(2009) 200:516–23. 10.1086/60038119572805 105.TandaleBVSathePSArankalleVAWadiaRSKulkarniRShahSVet al.. Systemic involvements and fatalities during" exact="chikungunya" post="epidemic in India, (2006). J Clin Virol. (2009) 46:145–9."/>
 <result pre="J Clin Virol. (2009) 46:145–9. 10.1016/j.jcv.2009.06.02719640780 106.JohnsonBWRussellBJGoodmanCH. Laboratory diagnosis of" exact="chikungunya" post="virus infections and commercial sources for diagnostic assays. J"/>
 <result pre="Virol. (2009) 46:145–9. 10.1016/j.jcv.2009.06.02719640780 106.JohnsonBWRussellBJGoodmanCH. Laboratory diagnosis of chikungunya virus" exact="infections" post="and commercial sources for diagnostic assays. J Infect Dis."/>
 <result pre="of immune competent mice, C57BL/6J using an Indian isolate of" exact="chikungunya" post="virus (CHIKV). Viruses. (2019) 11:578. 10.3390/v1106057831242674 108.PierroARossiniGGaibaniPFinarelliACMoroMLLandiniMPet al.. Persistence"/>
 <result pre="virus–specific antibodies in a cohort of patients followed from the" exact="acute" post="phase of infection after the 2007 outbreak in Italy."/>
 <result pre="a cohort of patients followed from the acute phase of" exact="infection" post="after the 2007 outbreak in Italy. N Microbes N"/>
 <result pre="N Microbes N Infect. (2015) 7:23–5. 10.1016/j.nmni.2015.04.00226106482 109.MalvyDEzzedineKMamani-MatsudaMAutranBTolouHReceveurMCet al.. Destructive" exact="arthritis" post="in a patient with chikungunya virus infection with persistent"/>
 <result pre="7:23–5. 10.1016/j.nmni.2015.04.00226106482 109.MalvyDEzzedineKMamani-MatsudaMAutranBTolouHReceveurMCet al.. Destructive arthritis in a patient with" exact="chikungunya" post="virus infection with persistent specific IgM antibodies. BMC Infect"/>
 <result pre="10.1016/j.nmni.2015.04.00226106482 109.MalvyDEzzedineKMamani-MatsudaMAutranBTolouHReceveurMCet al.. Destructive arthritis in a patient with chikungunya" exact="virus infection" post="with persistent specific IgM antibodies. BMC Infect Dis. (2009)"/>
 <result pre="109.MalvyDEzzedineKMamani-MatsudaMAutranBTolouHReceveurMCet al.. Destructive arthritis in a patient with chikungunya virus" exact="infection" post="with persistent specific IgM antibodies. BMC Infect Dis. (2009)"/>
 <result pre="9:200. 10.1186/1471-2334-9-20020003320 110.MizunoYKatoYTakeshitaNUjiieMKobayashiTKanagawaSet al.. Clinical and radiological features of imported" exact="chikungunya" post="fever in Japan: a study of six cases at"/>
 <result pre="broad and ultrapotent human monoclonal antibodies with therapeutic activity against" exact="chikungunya" post="virus. Cell Host Microbe. (2015) 18:86–95. 10.1016/j.chom.2015.06.00926159721 115.HawmanDWFoxJMAshbrookAWMayNASchroederKMTorresRMet al.."/>
 <result pre="virus. Cell Host Microbe. (2015) 18:86–95. 10.1016/j.chom.2015.06.00926159721 115.HawmanDWFoxJMAshbrookAWMayNASchroederKMTorresRMet al.. Pathogenic" exact="chikungunya" post="virus evades B cell responses to establish persistence. Cell"/>
 <result pre="of a recombinant human monoclonal antibody reduces the severity of" exact="chikungunya" post="virus disease in rhesus macaques. PLoS Neglect Trop Dis."/>
 <result pre="recombinant human monoclonal antibody reduces the severity of chikungunya virus" exact="disease" post="in rhesus macaques. PLoS Neglect Trop Dis. (2017) 11:e0005637."/>
 <result pre="Development of a highly protective combination monoclonal antibody therapy against" exact="chikungunya" post="virus. PLoS Pathog. (2013) 9:e1003312. 10.1371/journal.ppat.100331223637602 118.FricJBertin-MaghitSWangCINardinAWarterL. Use of"/>
 <result pre="9:e1003312. 10.1371/journal.ppat.100331223637602 118.FricJBertin-MaghitSWangCINardinAWarterL. Use of human monoclonal antibodies to treat" exact="chikungunya" post="virus infection. J Infect Dis. (2013) 207:319–22. 10.1093/infdis/jis67423125446 119.HawmanDWStoermerKAMontgomerySAPalPOkoLDiamondMSet"/>
 <result pre="10.1371/journal.ppat.100331223637602 118.FricJBertin-MaghitSWangCINardinAWarterL. Use of human monoclonal antibodies to treat chikungunya" exact="virus infection." post="J Infect Dis. (2013) 207:319–22. 10.1093/infdis/jis67423125446 119.HawmanDWStoermerKAMontgomerySAPalPOkoLDiamondMSet al.. Chronic"/>
 <result pre="virus infection. J Infect Dis. (2013) 207:319–22. 10.1093/infdis/jis67423125446 119.HawmanDWStoermerKAMontgomerySAPalPOkoLDiamondMSet al.." exact="Chronic" post="joint disease caused by persistent chikungunya virus infection is"/>
 <result pre="infection. J Infect Dis. (2013) 207:319–22. 10.1093/infdis/jis67423125446 119.HawmanDWStoermerKAMontgomerySAPalPOkoLDiamondMSet al.. Chronic" exact="joint disease" post="caused by persistent chikungunya virus infection is controlled by"/>
 <result pre="J Infect Dis. (2013) 207:319–22. 10.1093/infdis/jis67423125446 119.HawmanDWStoermerKAMontgomerySAPalPOkoLDiamondMSet al.. Chronic joint" exact="disease" post="caused by persistent chikungunya virus infection is controlled by"/>
 <result pre="207:319–22. 10.1093/infdis/jis67423125446 119.HawmanDWStoermerKAMontgomerySAPalPOkoLDiamondMSet al.. Chronic joint disease caused by persistent" exact="chikungunya" post="virus infection is controlled by the adaptive immune response."/>
 <result pre="10.1093/infdis/jis67423125446 119.HawmanDWStoermerKAMontgomerySAPalPOkoLDiamondMSet al.. Chronic joint disease caused by persistent chikungunya" exact="virus infection" post="is controlled by the adaptive immune response. J Virol."/>
 <result pre="119.HawmanDWStoermerKAMontgomerySAPalPOkoLDiamondMSet al.. Chronic joint disease caused by persistent chikungunya virus" exact="infection" post="is controlled by the adaptive immune response. J Virol."/>
 <result pre="pathogen clearance. Cell Microbiol. (2007) 9:2095–102. 10.1111/j.1462-5822.2007.00981.x17590164 123.CarpentierKSDavenportBJHaistKCMcCarthyMKMayNARobisonAet al.. Discrete" exact="viral" post="E2 lysine residues and scavenger receptor MARCO are required"/>
 <result pre="Nature. (1991) 350:423–6. 10.1038/350423a01901381 125.WesselsMRButkoPMaMWarrenHBLageALCarrollMC. Studies of group B streptococcal" exact="infection" post="in mice deficient in complement component C3 or C4"/>
 <result pre="demonstrate an essential role for complement in both innate and" exact="acquired" post="immunity. Proc Natl Acad Sci USA. (1995) 92:11490–4. 10.1073/pnas.92.25.114908524789"/>
 <result pre="resolution of inflammation. Sem Immunol. (2015). 227–33. 10.1016/j.smim.2015.05.00426095908 131.MirakajVDalliJGranjaTRosenbergerPSerhanCN. Vagus" exact="nerve" post="controls resolution and pro-resolving mediators of inflammation. J Exp"/>
 <result pre="inflammation. J Exp Med. (2014) 211:1037–48. 10.1084/jem.2013210324863066 132.PavlovVATraceyKJ. The vagus" exact="nerve" post="and the inflammatory reflex—linking immunity and metabolism. Nat Rev"/>
 <result pre="onset?Front Immunol. (2016) 7:160. 10.3389/fimmu.2016.0016027199985 135.WilsonJAProwNASchroderWAEllisJJCummingHEGearingLJet al.. RNA-Seq analysis of" exact="chikungunya" post="virus infection and identification of granzyme A as a"/>
 <result pre="Immunol. (2016) 7:160. 10.3389/fimmu.2016.0016027199985 135.WilsonJAProwNASchroderWAEllisJJCummingHEGearingLJet al.. RNA-Seq analysis of chikungunya" exact="virus infection" post="and identification of granzyme A as a major promoter"/>
 <result pre="(2016) 7:160. 10.3389/fimmu.2016.0016027199985 135.WilsonJAProwNASchroderWAEllisJJCummingHEGearingLJet al.. RNA-Seq analysis of chikungunya virus" exact="infection" post="and identification of granzyme A as a major promoter"/>
 <result pre="and identification of granzyme A as a major promoter of" exact="arthritic" post="inflammation. PLoS Pathog. (2017) 13:e1006155. 10.1371/journal.ppat.100615528207896 136.WangNLiangHZenK. Molecular mechanisms"/>
 <result pre="Hypoxia-inducible factor 2α regulates macrophage function in mouse models of" exact="acute" post="and tumor inflammation. J Clin Invest. (2010) 120:2699–714. 10.1172/JCI3950620644254"/>
 <result pre="2α regulates macrophage function in mouse models of acute and" exact="tumor" post="inflammation. J Clin Invest. (2010) 120:2699–714. 10.1172/JCI3950620644254 138.StoermerKABurrackAOkoLMontgomerySABorstLBGillRGet al.."/>
 <result pre="action. Trends Biochem Sci. (2004) 29:462–8. 10.1016/j.tibs.2004.07.00115337119 141.GhoshZMallickBChakrabartiJ. Cellular versus" exact="viral" post="microRNAs in host–virus interaction. Nucleic Acids Res. (2008) 37:1035–48."/>
 <result pre="in host–virus interaction. Nucleic Acids Res. (2008) 37:1035–48. 10.1093/nar/gkn100419095692 142.GottweinECullenBR." exact="Viral" post="and cellular microRNAs as determinants of viral pathogenesis and"/>
 <result pre="37:1035–48. 10.1093/nar/gkn100419095692 142.GottweinECullenBR. Viral and cellular microRNAs as determinants of" exact="viral" post="pathogenesis and immunity. Cell Host Microbe. (2008) 3:375–87. 10.1016/j.chom.2008.05.00218541214"/>
 <result pre="Microbe. (2008) 3:375–87. 10.1016/j.chom.2008.05.00218541214 143.ChatzikyriakidouAVoulgariPVGeorgiouIDrososAA. miRNAs and related polymorphisms in" exact="rheumatoid arthritis" post="susceptibility. Autoimmun Rev. (2012) 11:636–41. 10.1016/j.autrev.2011.11.00422100329 144.Kurowska-StolarskaMAliverniniSBallantineLEAsquithDLMillarNLGilchristDSet al.. MicroRNA-155"/>
 <result pre="(2008) 3:375–87. 10.1016/j.chom.2008.05.00218541214 143.ChatzikyriakidouAVoulgariPVGeorgiouIDrososAA. miRNAs and related polymorphisms in rheumatoid" exact="arthritis" post="susceptibility. Autoimmun Rev. (2012) 11:636–41. 10.1016/j.autrev.2011.11.00422100329 144.Kurowska-StolarskaMAliverniniSBallantineLEAsquithDLMillarNLGilchristDSet al.. MicroRNA-155"/>
 <result pre="mammalian fibroblast cells. Virus Genes. (2018) 54:502–13. 10.1007/s11262-018-1578-829872954 146.SaxenaTTandonBSharmaSChameettachalSRayPRayARet al.." exact="Combined" post="miRNA and mRNA signature identifies key molecular players and"/>
 <result pre="mRNA signature identifies key molecular players and pathways involved in" exact="chikungunya" post="virus infection in human cells. PLoS ONE. (2013) 8:e79886."/>
 <result pre="signature identifies key molecular players and pathways involved in chikungunya" exact="virus infection" post="in human cells. PLoS ONE. (2013) 8:e79886. 10.1371/journal.pone.007988624278205 147.SelvamaniSPMishraRSinghSK."/>
 <result pre="identifies key molecular players and pathways involved in chikungunya virus" exact="infection" post="in human cells. PLoS ONE. (2013) 8:e79886. 10.1371/journal.pone.007988624278205 147.SelvamaniSPMishraRSinghSK."/>
 <result pre="(2018) 19:730. 10.3390/ijms1903073029510522 159.LeeWWTeoTHHerZLumFMKamYWHaaseDet al.. Expanding regulatory T cells alleviates" exact="chikungunya" post="virus-induced pathology in mice. J Virol. (2015) 89:7893–904. 10.1128/JVI.00998-1525995249"/>
 <result pre="receptor family. Nat Rev Immunol. (2009) 9:556–67. 10.1038/nri258619575028 161.KoendersMIMarijnissenRJDevesaILubbertsEJoostenLARothJet al.." exact="Tumor" post="necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1beta, and matrix metalloproteinases,"/>
 <result pre="destruction in murine arthritis: rationale for combination treatment during arthritis." exact="Arthritis" post="Rheum. (2011) 63:2329–39. 10.1002/art.3041821520013 162.ChaaitanyaIKMuruganandamNSundaramSGKawalekarOSugunanAPManimundaSPet al.. Role of proinflammatory"/>
 <result pre="10.1002/art.3041821520013 162.ChaaitanyaIKMuruganandamNSundaramSGKawalekarOSugunanAPManimundaSPet al.. Role of proinflammatory cytokines and chemokines in" exact="chronic" post="arthropathy in CHIKV infection. Viral Immunol. (2011) 24:265–71. 10.1089/vim.2010.012321830898"/>
 <result pre="162.ChaaitanyaIKMuruganandamNSundaramSGKawalekarOSugunanAPManimundaSPet al.. Role of proinflammatory cytokines and chemokines in chronic" exact="arthropathy" post="in CHIKV infection. Viral Immunol. (2011) 24:265–71. 10.1089/vim.2010.012321830898 163.NgLFChowASunYJKwekDJLimPLDimatatacFet"/>
 <result pre="Role of proinflammatory cytokines and chemokines in chronic arthropathy in" exact="CHIKV infection." post="Viral Immunol. (2011) 24:265–71. 10.1089/vim.2010.012321830898 163.NgLFChowASunYJKwekDJLimPLDimatatacFet al.. IL-1beta, IL-6,"/>
 <result pre="proinflammatory cytokines and chemokines in chronic arthropathy in CHIKV infection." exact="Viral" post="Immunol. (2011) 24:265–71. 10.1089/vim.2010.012321830898 163.NgLFChowASunYJKwekDJLimPLDimatatacFet al.. IL-1beta, IL-6, and"/>
 <result pre="10.1089/vim.2010.012321830898 163.NgLFChowASunYJKwekDJLimPLDimatatacFet al.. IL-1beta, IL-6, and RANTES as biomarkers of" exact="chikungunya" post="severity. PLoS ONE. (2009) 4:e4261. 10.1371/journal.pone.000426119156204 164.LohachanakulJPhukliaWThannagithMThonsakulprasertTUbolS. High concentrations"/>
 <result pre="(2009) 4:e4261. 10.1371/journal.pone.000426119156204 164.LohachanakulJPhukliaWThannagithMThonsakulprasertTUbolS. High concentrations of circulating interleukin-6 and" exact="monocyte" post="chemotactic protein-1 with low concentrations of interleukin-8 were associated"/>
 <result pre="protein-1 with low concentrations of interleukin-8 were associated with severe" exact="chikungunya" post="fever during the 2009-2010 outbreak in Thailand. Microbiol Immunol."/>
 <result pre="10.1111/j.1348-0421.2011.00417.x22188545 165.ManetCSimon-LorièreEJouvionGHardyDProtMConquetLet al.. Genetic diversity of collaborative cross mice controls" exact="viral" post="replication, clinical severity and brain pathology induced by zika"/>
 <result pre="viral replication, clinical severity and brain pathology induced by zika" exact="virus infection," post="independently of Oas1b. J Virol. (2019) 94:e01034–19. 10.1101/67748431694939 166.RosserECMauriC."/>
 <result pre="and transitional subsets in healthy donors but are deficient in" exact="chronic" post="GVHD. Blood. (2014) 124:2034–45. 10.1182/blood-2014-04-57112525051962 170.MauriCMenonM. The expanding family"/>
 <result pre="expression, function and response to inflammatory stimuli of 11beta-hydroxysteroid dehydrogenase" exact="type 1" post="in human fibroblasts: a mechanism for tissue-specific regulation of"/>
 <result pre="in human fibroblasts: a mechanism for tissue-specific regulation of inflammation." exact="Arthritis" post="Res Ther. (2006) 8:R108. 10.1186/ar199316846535 174.CuiDZhangLChenJZhuMHouLChenBet al.. Changes in"/>
 <result pre="al.. Changes in regulatory B cells and their relationship with" exact="rheumatoid arthritis" post="disease activity. Clin Exp Med. (2015) 15:285–92. 10.1007/s10238-014-0310-925245953 175.LorenzettiRJanowskaISmulskiCRFredeNHennebergerNWalterLet"/>
 <result pre="Changes in regulatory B cells and their relationship with rheumatoid" exact="arthritis" post="disease activity. Clin Exp Med. (2015) 15:285–92. 10.1007/s10238-014-0310-925245953 175.LorenzettiRJanowskaISmulskiCRFredeNHennebergerNWalterLet"/>
 <result pre="in regulatory B cells and their relationship with rheumatoid arthritis" exact="disease" post="activity. Clin Exp Med. (2015) 15:285–92. 10.1007/s10238-014-0310-925245953 175.LorenzettiRJanowskaISmulskiCRFredeNHennebergerNWalterLet al.."/>
 <result pre="human B-cells. J Autoimmun. (2019) 101:145–52. 10.1016/j.jaut.2019.04.01631054942 176.SissokoDMalvyDEzzedineKRenaultPMoscettiFLedransMet al.. Post-epidemic" exact="chikungunya" post="disease on Reunion Island: course of rheumatic manifestations and"/>
 <result pre="B-cells. J Autoimmun. (2019) 101:145–52. 10.1016/j.jaut.2019.04.01631054942 176.SissokoDMalvyDEzzedineKRenaultPMoscettiFLedransMet al.. Post-epidemic chikungunya" exact="disease" post="on Reunion Island: course of rheumatic manifestations and associated"/>
 <result pre="176.SissokoDMalvyDEzzedineKRenaultPMoscettiFLedransMet al.. Post-epidemic chikungunya disease on Reunion Island: course of" exact="rheumatic" post="manifestations and associated factors over a 15-month period. PLoS"/>
 <result pre="15-month period. PLoS Negl Trop Dis. (2009) 3:e389. 10.1371/journal.pntd.000038919274071 177.ChopraAAnuradhaVGhorpadeRSalujaM." exact="Acute" post="chikungunya and persistent musculoskeletal pain following the 2006 Indian"/>
 <result pre="period. PLoS Negl Trop Dis. (2009) 3:e389. 10.1371/journal.pntd.000038919274071 177.ChopraAAnuradhaVGhorpadeRSalujaM. Acute" exact="chikungunya" post="and persistent musculoskeletal pain following the 2006 Indian epidemic:"/>
 <result pre="Chikungunya-related arthritis: case report and review of the literature. Semin" exact="Arthritis" post="Rheum. (2013) 43:273–8. 10.1016/j.semarthrit.2013.03.00323608542 179.AnfasaFProvaciaLGeurtsvanKesselCWeverRGerstenbluthIOsterhausADet al.. Hyperferritinemia is a"/>
 <result pre="the literature. Semin Arthritis Rheum. (2013) 43:273–8. 10.1016/j.semarthrit.2013.03.00323608542 179.AnfasaFProvaciaLGeurtsvanKesselCWeverRGerstenbluthIOsterhausADet al.." exact="Hyperferritinemia" post="is a potential marker of chronic chikungunya: a retrospective"/>
 <result pre="43:273–8. 10.1016/j.semarthrit.2013.03.00323608542 179.AnfasaFProvaciaLGeurtsvanKesselCWeverRGerstenbluthIOsterhausADet al.. Hyperferritinemia is a potential marker of" exact="chronic" post="chikungunya: a retrospective study on the Island of Curacao"/>
 <result pre="2014-2015 outbreak. J Clin Virol. (2017) 86:31–8. 10.1016/j.jcv.2016.11.00327912127 180.KelvinAABannerDSilviGMoroMLSpataroNGaibaniPet al.." exact="Inflammatory" post="cytokine expression is associated with chikungunya virus resolution and"/>
 <result pre="86:31–8. 10.1016/j.jcv.2016.11.00327912127 180.KelvinAABannerDSilviGMoroMLSpataroNGaibaniPet al.. Inflammatory cytokine expression is associated with" exact="chikungunya" post="virus resolution and symptom severity. PLoS Negl Trop Dis."/>
 <result pre="Dis. (2011) 5:e1279. 10.1371/journal.pntd.000127921858242 181.ChowAHerZOngEKChenJMDimatatacFKwekDJet al.. Persistent arthralgia induced by" exact="chikungunya" post="virus infection is associated with interleukin-6 and granulocyte macrophage"/>
 <result pre="(2011) 5:e1279. 10.1371/journal.pntd.000127921858242 181.ChowAHerZOngEKChenJMDimatatacFKwekDJet al.. Persistent arthralgia induced by chikungunya" exact="virus infection" post="is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor."/>
 <result pre="5:e1279. 10.1371/journal.pntd.000127921858242 181.ChowAHerZOngEKChenJMDimatatacFKwekDJet al.. Persistent arthralgia induced by chikungunya virus" exact="infection" post="is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor."/>
 <result pre="Jesus BarretoMCristiny PereiraMda Rocha PittaIet al.. IL-27 in patients with" exact="chikungunya" post="fever: a possible chronicity biomarker?Acta Trop. (2019) 196:48–51. 10.1016/j.actatropica.2019.05.00531075222"/>
 <result pre="chronicity biomarker?Acta Trop. (2019) 196:48–51. 10.1016/j.actatropica.2019.05.00531075222 183.YoungARLockeMCCookLEHillerBEZhangRHedbergMLet al.. Dermal and" exact="muscle" post="fibroblasts and skeletal myofibers survive chikungunya virus infection and"/>
 <result pre="183.YoungARLockeMCCookLEHillerBEZhangRHedbergMLet al.. Dermal and muscle fibroblasts and skeletal myofibers survive" exact="chikungunya" post="virus infection and harbor persistent RNA. PLoS Pathog. (2019)."/>
 <result pre="al.. Dermal and muscle fibroblasts and skeletal myofibers survive chikungunya" exact="virus infection" post="and harbor persistent RNA. PLoS Pathog. (2019). 15:e1007993. 10.1371/journal.ppat.100799331465513"/>
 <result pre="Dermal and muscle fibroblasts and skeletal myofibers survive chikungunya virus" exact="infection" post="and harbor persistent RNA. PLoS Pathog. (2019). 15:e1007993. 10.1371/journal.ppat.100799331465513"/>
 <result pre="154:29–39. 10.1093/jb/mvt04923750028 185.AmdekarSParasharDAlagarasuK. Chikungunya virus-induced arthritis: role of host and" exact="viral" post="factors in the pathogenesis. Viral Immunol. (2017) 30:691–702. 10.1089/vim.2017.005228910194"/>
 <result pre="arthritis: role of host and viral factors in the pathogenesis." exact="Viral" post="Immunol. (2017) 30:691–702. 10.1089/vim.2017.005228910194 186.GueganJPLegembreP. Nonapoptotic functions of Fas/CD95"/>
 <result pre="285:809–27. 10.1111/febs.1429229032605 187.NoretMHerreroLRulliNRolphMSmithPNLiRWet al.Interleukin 6, RANKL, and osteoprotegerin expression by" exact="chikungunya" post="virus-infected human osteoblasts. J Infect Dis. (2012) 206:455–7:7–9. 10.1093/infdis/jis368"/>
 <result pre="complex signaling pathways for the recruitment of gene-specific transcription factors." exact="Arthritis" post="Res. (2002) 4:157–64. 10.1186/ar40112010565"/>
</results>
